Familial hypercholesterolemia

E4_FH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E78.00 Hospital discharge: ICD-9 — 2720A Cause of death: ICD-10 — E78.00 Cause of death: ICD-9 — 2720A 2 out of 7 registries used, show all original rules.	6910
4. Check minimum number of events None	6910
5. Include endpoints None	6910
6. Filter based on genotype QC (FinnGen only)	6732

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF6v3

NAME	E4_FH
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E7800
HD_ICD_9	2720A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E7800
COD_ICD_9	2720A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Familial hypercholesterolemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Familial hypercholesterolemia, with ischemic heart disease

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	51090	24106	26865
Only index persons	48827	23192	25635
Unadjusted period prevalence (%)
Whole population	0.72	0.69	0.75
Only index persons	0.92	0.85	0.98
Median age at first event (years)
Whole population	68.34	71.31	65.66
Only index persons	68.32	71.27	65.66

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6732	2821	3911
Unadjusted period prevalence (%)	1.46	1.00	1.79
Median age at first event (years)	65.88	66.40	65.51

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6910: Matched controls
69100

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.8

323.0

2284

10349

C10AA07

ATC

rosuvastatin; oral

2.9

307.7

2891

13834

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.3

307.7

2934

12686

C01DA14

ATC

isosorbide mononitrate; oral

3.6

307.7

2144

7667

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

54741.3

307.7

6867

201

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

12.5

307.7

3408

4976

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

5.0

307.7

1248

2894

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

4.0

307.7

2566

8818

I10

ICD-10 Finland

Essential (primary) hypertension

4.1

307.7

5644

36082

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

16.5

307.7

1489

1129

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.9

307.7

2880

10657

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.7

307.7

701

1346

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

5.3

307.7

1010

2154

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

6.1

307.7

596

1054

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.4

307.7

1499

4114

C10AA01

ATC

simvastatin; oral

6.2

307.7

5249

23419

I25.2

ICD-10 Finland

Old myocardial infarction

4.4

307.7

1009

2594

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

6.3

307.7

632

1089

C07AB07

ATC

bisoprolol; oral

2.7

307.7

4464

27839

B01AC04

ATC

clopidogrel; oral

4.6

307.7

2369

7000

AN1

Coronary angiography

5.2

307.7

1856

4584

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

5.2

307.7

746

1579

211

Kela drug reimbursment

Severe hereditary disorders of lipid metabolism (familial hypercholesterolaemia and type III dyslipoproteinemia)

64.7

307.7

431

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

30.6

307.7

631

226

C10AX09

ATC

ezetimibe; oral

5.1

307.7

2070

5377

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.2

307.7

3131

11353

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

5.2

307.7

1220

2713

C10AA05

ATC

atorvastatin; oral

4.4

307.7

4570

21273

I20.00

ICD-10 Finland

Unstable angina

7.0

307.7

579

885

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.1

307.7

2620

11349

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

4.7

307.3

770

1792

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

4.9

306.7

721

1592

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.7

292.7

2320

11044

T90

ICPC

Diabetes non-insulin dependent

2.6

289.7

2355

11340

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

286.6

2299

10990

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.4

285.5

1210

4076

AN4

Balloon angioplasty and drug eluding stent

6.1

283.9

514

895

C10AA04

ATC

fluvastatin; oral

3.6

280.7

1084

3440

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

13.2

279.3

268

210

I20.09

ICD-10 Finland

Unstable angina

4.3

275.6

774

1964

103

Kela drug reimbursment

Diabetes, insulin-treated

2.5

272.2

2569

13204

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.4

270.9

738

1829

A10BA02

ATC

metformin; oral

2.5

269.0

2685

14144

Angiography of the heart and coronary arteries

3.8

264.3

882

2533

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

252.2

2477

12875

C03CA01

ATC

furosemide; systemic

2.3

241.4

3028

17426

B04AB02, ,

ATC

7.2

238.1

365

534

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.1

232.4

1104

3952

I20.90

ICD-10 Finland

Angina pectoris, unspecified

5.0

231.9

525

1117

A10AE04

ATC

insulin glargine; parenteral

3.3

229.2

984

3315

C09AA05

ATC

ramipril; oral

2.3

220.6

2436

13171

C10AA02

ATC

lovastatin; oral

4.4

218.4

576

1386

C10AA03

ATC

pravastatin; oral

3.5

213.3

823

2588

AN3

Balloon angioplasty and metallic stent

5.4

204.4

419

816

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.2

203.6

890

3020

C08CA01

ATC

amlodipine; oral

2.1

199.0

3342

21133

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

196.6

1102

4301

E86

ICD-10 Finland

Volume depletion

20.2

195.5

150

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

195.2

1575

7359

XF402

NOMESCO Finland

ECG with work load test

2.9

194.9

1046

3986

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.4

193.8

759

2404

SPAT1262

SPAT

Handing over of treatment supplies

2.4

188.8

1654

8007

205

Kela drug reimbursment

Chronic hypertension

2.1

187.9

2631

15433

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

31.0

186.9

122

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.7

186.3

629

1806

C10AX13

ATC

evolocumab; parenteral

34.3

186.2

118

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.4

184.7

731

2328

ZXD05

NOMESCO Finland

Urgent procedure

2.2

183.3

2337

13194

A10AB05

ATC

insulin aspart; parenteral

3.4

182.7

733

2354

E66.00

ICD-10 Finland

Metabolic syndrome

4.1

177.5

511

1310

I20.01

ICD-10 Finland

Unstable angina

4.9

176.1

405

870

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

5.1

174.4

378

772

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.8

169.7

545

1510

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.0

168.9

822

2955

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

2.3

166.8

1605

8040

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

3.8

165.6

548

1549

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

164.3

1628

8249

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.9

160.7

505

1377

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

159.6

3625

24858

AA1

Conventional CABG

5.8

158.2

295

525

N02BE01

ATC

paracetamol; systemic, rectal

3.0

157.8

6272

53029

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

156.2

2400

14350

Single vessel balloon catheter extension

5.3

153.7

321

634

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

153.3

1661

8696

C07AB02

ATC

metoprolol; systemic

2.1

153.1

1889

10404

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

150.3

1461

7312

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

6.5

148.0

247

394

C10AC02

ATC

colestipol; oral

20.3

146.7

112

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

5.3

145.1

300

587

AA1AD

NOMESCO Finland

CT of head and brain

2.0

138.6

2221

13360

A02BC02

ATC

pantoprazole; systemic

1.9

132.2

4793

37293

E87.5

ICD-10 Finland

Hyperkalaemia

12.1

131.3

132

111

R06.0

ICD-10 Finland

Dyspnoea

2.0

129.3

2080

12473

E87.6

ICD-10 Finland

Hypokalaemia

7.4

128.6

189

263

A28

ICPC

Limited function/disability NOS

2.1

128.1

1601

8777

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

3.0

125.4

606

2157

A10BH01

ATC

sitagliptin; oral

2.5

125.1

886

3834

SPAT1254

SPAT

Administration of medicine

2.2

124.8

1319

6776

A10AE05

ATC

insulin detemir; parenteral

3.3

121.1

482

1530

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

7.3

119.6

177

248

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

119.3

1321

6897

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.6

119.3

412

1194

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

119.1

634

2377

C10AB05

ATC

fenofibrate; oral

6.1

118.6

210

355

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

118.5

2266

14298

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

118.1

1393

7446

280

Kela drug reimbursment

Clopidogrel

5.9

117.5

214

372

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

4.6

115.6

283

638

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.4

115.5

436

1338

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.8

115.2

615

2308

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

5.6

114.7

219

398

E66.01

ICD-10 Finland

Obesity due to excess calories

3.1

113.4

507

1724

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

112.4

2197

13910

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

112.1

454

1455

388

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of familial hypercholesterolaemia

+∞

110.7

106

G47.3

ICD-10 Finland

Sleep apnoea

2.0

110.4

1584

9059

N03AX16

ATC

[U] pregabalin

1.9

108.6

1689

9918

J01DB01

ATC

cefalexin; oral

2.0

107.5

5527

46291

292

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of familial hypercholesterolaemia

+∞

105.5

101

I25

ICD-10 Finland

Chronic ischaemic heart disease

3.0

104.9

497

1745

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

104.8

421

1342

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.3

103.2

400

1247

L28

ICPC

Limited function/disability (L)

2.0

103.0

1481

8449

C10AB02

ATC

bezafibrate; oral

6.2

102.0

176

290

N02AX02

ATC

tramadol; systemic, rectal

1.7

102.0

3079

21967

B01AA03

ATC

warfarin; systemic

1.9

100.9

1794

10962

R42

ICD-10 Finland

Dizziness and giddiness

1.9

100.9

1753

10634

SPAT1263

SPAT

Sampling

1.7

100.0

2933

20723

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

99.9

2285

15055

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.0

97.5

451

1561

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

96.7

2043

13126

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

96.0

609

2488

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

93.6

1187

6460

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.4

93.5

239

557

A10AC01

ATC

insulin (human); parenteral

2.5

92.9

609

2526

B04AD02, ,

ATC

23.3

92.9

C03DA01

ATC

spironolactone; oral

2.1

92.8

1005

5162

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.3

89.3

357

1133

A10BJ06

ATC

semaglutide; parenteral

3.3

88.3

355

1130

N02AA05

ATC

oxycodone; systemic

1.8

87.3

1499

9000

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

4.2

86.9

233

563

AN2

Balloon angioplasty, including several vessels

3.6

86.9

302

877

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

7.2

86.2

129

183

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

5.3

85.9

176

341

A10BB12

ATC

glimepiride; oral

2.4

85.2

661

2958

A10BK03

ATC

empagliflozin; oral

2.3

85.2

750

3542

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

6.3

82.9

141

229

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

82.5

2915

21296

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

4.9

81.3

181

377

R53

ICD-10 Finland

Malaise and fatigue

1.8

81.0

1561

9680

B01AB05

ATC

enoxaparin; parenteral

1.7

80.8

2298

15864

R07.3

ICD-10 Finland

Other chest pain

2.2

80.5

754

3647

WX872

NOMESCO Finland

Intensive care

2.7

79.8

442

1683

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.6

79.6

274

790

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.9

79.5

175

361

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

79.3

1759

11345

C03AA03

ATC

hydrochlorothiazide; oral

2.1

78.2

799

3998

I50.0

ICD-10 Finland

Congestive heart failure

2.2

77.6

717

3447

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

77.5

921

4873

E78.11

ICD-10 Finland

Other hypertriglyceridemia

19.5

77.2

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

76.6

1501

9331

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

6.4

76.2

127

202

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

75.6

1989

13405

C08CA13

ATC

lercanidipine; oral

1.9

75.3

1134

6500

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.1

74.5

211

531

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

73.4

2590

18757

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.9

72.9

1175

6875

M79.6

ICD-10 Finland

Pain in limb

1.6

72.7

2585

18744

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

72.6

1247

7440

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

72.2

1014

5673

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.7

71.7

166

357

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

71.5

1117

6469

M04AA01

ATC

allopurinol; systemic

1.9

71.3

1128

6556

K90

ICPC

Stroke/cerebrovascular accident

3.2

71.1

288

920

2720A

ICD-9 Finland

Disorders of lipoid metabolism, Pure hypercholesterolaemia[HYPERCHOLESTEROLAEMIA FAMILIARIS (FHK)]

+∞

70.9

E78.49

ICD-10 Finland

Other hyperlipidaemia

9.2

70.7

N03AX12

ATC

[U] gabapentin; oral

1.9

70.7

1111

6444

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

70.0

1263

7640

M10.9

ICD-10 Finland

Gout, unspecified

2.2

69.9

609

2854

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.7

69.9

162

349

J01MA12

ATC

levofloxacin; systemic

1.8

69.8

1402

8750

A10BH05

ATC

linagliptin; oral

2.5

69.6

456

1885

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

69.1

2594

18990

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

68.8

344

1240

A10BK01

ATC

dapagliflozin; oral

2.3

68.4

538

2414

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

68.3

2222

15714

E66.8

ICD-10 Finland

Other obesity

3.2

67.8

279

900

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

67.4

1014

5793

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.2

66.7

576

2688

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.6

66.3

161

360

C09AA02

ATC

enalapril; systemic

1.7

66.1

1560

10156

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.4

66.1

471

2022

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

7.5

66.0

129

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.9

65.6

311

1088

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.3

65.4

105

J01FF01

ATC

clindamycin; systemic

1.6

64.7

1762

11897

B04AB01, ,

ATC

4.6

64.5

153

336

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

4.0

64.4

189

488

R55

ICD-10 Finland

Syncope and collapse

1.9

64.4

861

4726

160

Kela drug reimbursment

exenatide

4.2

64.0

170

408

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.2

63.6

131

255

SPAT1216

SPAT

Assessment of functional ability

1.7

63.6

1283

7993

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.3

63.3

246

766

R51.80

ICD-10 Finland

Headache

2.0

63.2

821

4462

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.2

63.2

257

823

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.3

63.1

484

2147

T89

ICPC

Diabetes insulin dependent

3.3

62.4

241

748

SPAT1252

SPAT

Overall medication plan or its review

2.2

62.0

598

2915

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

61.8

2046

14458

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.8

61.5

139

293

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

12.6

61.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

61.0

732

3869

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

60.7

1402

9051

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

60.4

2520

18738

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.7

60.3

142

310

C02AC05

ATC

moxonidine; oral

2.6

60.2

372

1493

M54.5

ICD-10 Finland

Low back pain

1.6

59.5

2074

14801

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

59.3

556

2678

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.8

59.2

108

188

A10AB04

ATC

insulin lispro; parenteral

3.6

58.9

199

567

B01AC07

ATC

dipyridamole; systemic

2.4

58.8

429

1860

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

4.0

58.5

170

436

S18

ICPC

Laceration/cut

1.5

58.4

3149

24672

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

58.1

535

2558

WX722

NOMESCO Finland

PEEP

2.5

58.1

378

1555

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.1

58.0

249

823

Coronary artery bypass surgery

3.2

57.7

233

743

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

57.6

1054

6367

H36.01

ICD-10 Finland

Diabetic maculopathy

4.9

57.4

127

263

H02AB06

ATC

prednisolone; systemic

1.5

57.4

3129

24543

ZX120

NOMESCO Finland

Intravenous

2.0

57.3

662

3448

R11

ICD-10 Finland

Nausea and vomiting

2.1

57.3

557

2721

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

57.0

739

4006

I20.91

ICD-10 Finland

Angina pectoris, unspecified

4.3

57.0

147

345

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

56.9

903

5225

207

Kela drug reimbursment

Chronic arrhythmias

1.7

56.6

1327

8580

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.1

56.4

589

2956

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

3.3

56.4

217

672

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

55.7

989

5919

PE1AT

NOMESCO Finland

Femoral artery PTA

4.5

55.7

138

314

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

6.9

55.0

125

SPAT1325

SPAT

Vaccination

1.5

54.9

2452

18402

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

54.8

1622

11103

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

12.4

54.7

315

Kela drug reimbursment

Clopidogrel

4.7

54.2

127

276

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

54.0

1432

9540

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

53.9

598

3068

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

6.0

53.5

161

N30.0

ICD-10 Finland

Acute cystitis

1.8

53.4

993

6018

UJF32

NOMESCO Finland

Coloscopy

1.6

53.2

1838

13030

Catheterization and pressure measurement of the left side of the heart

3.6

53.1

179

509

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

3.6

53.0

174

486

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

52.7

469

2211

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

52.4

1176

7501

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.7

52.4

289

1096

C09CA01

ATC

losartan; oral

1.6

52.3

1841

13095

A04

ICPC

Weakness/tiredness general

1.8

52.0

954

5756

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.1

51.8

145

362

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

51.8

1247

8099

J01MA02

ATC

ciprofloxacin; systemic

1.5

51.5

2675

20634

ZXA05

NOMESCO Finland

Left side

1.6

51.3

1718

12074

R03AC02

ATC

salbutamol; inhalant

1.5

51.3

3201

25588

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.1

51.3

223

743

SPAT1097

SPAT

Recording of ECG

1.7

51.2

1101

6938

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

51.2

836

4872

SPAT1229

SPAT

Assessment of need for aid

2.0

51.0

639

3419

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.7

50.5

118

256

SPAT1310

SPAT

Counselling related to known health issue

1.5

50.5

2064

15142

A06AD11

ATC

lactulose; oral

1.7

50.5

1145

7317

A10BX01

ATC

guar gum; oral

2.5

50.0

327

1348

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

49.9

432

2012

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

4.9

49.9

111

231

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.4

49.9

180

535

E78.10

ICD-10 Finland

Familial hypertriglyceridemia

108.9

49.8

A10BJ02

ATC

liraglutide; parenteral

3.3

49.7

186

566

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

49.5

392

1759

K29

ICPC

Cardiovascular sympt/complt other

2.3

49.3

384

1712

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.0

49.2

219

739

A46

ICD-10 Finland

Erysipelas

1.7

49.1

1084

6873

A02BC05

ATC

esomeprazole; systemic

1.5

49.1

2532

19448

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

48.9

518

2609

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

48.7

728

4124

UKC02

NOMESCO Finland

Cystoscopy

1.6

48.5

1307

8715

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

48.0

739

4224

Z3231

NOMESCO Finland

Registered nurse

1.5

48.0

1760

12591

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

47.9

549

2846

N06AX21

ATC

duloxetine; oral

1.9

47.9

636

3468

E78.2

ICD-10 Finland

Mixed hyperlipidaemia

15.9

47.7

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

47.7

757

4367

WX882

NOMESCO Finland

High dependency care

2.9

47.6

228

802

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

47.6

847

5056

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

47.6

1144

7411

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

47.4

756

4369

N06AX11

ATC

mirtazapine; oral

1.5

47.3

2002

14750

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

47.3

556

2907

A29

ICPC

General symptom/complaint other

1.7

47.3

894

5430

B01AC24

ATC

ticagrelor; oral

2.6

47.2

277

1083

V03AE01

ATC

polystyrene sulfonate; oral

4.4

46.8

117

268

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

8.5

46.8

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

46.7

1025

6482

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

46.7

495

2494

N05CF01

ATC

zopiclone; oral

1.5

46.6

2152

16130

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

4.0

46.6

135

346

M48.0

ICD-10 Finland

Spinal stenosis

1.7

46.5

957

5947

P01AB01

ATC

metronidazole; oral, rectal

1.5

46.5

2246

16983

H25.8

ICD-10 Finland

Other senile cataract

1.7

46.4

960

5974

H3603, E103,

ICD-10 Finland

7.9

46.4

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

46.3

4154

35260

PEN23

NOMESCO Finland

Plastic repair of femoral artery

5.1

46.3

192

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

46.2

3128

25210

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

46.2

2628

20504

S97

ICPC

Chronic ulcer skin

2.1

46.1

485

2437

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

45.9

914

5627

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

45.9

766

4485

C10AB04

ATC

gemfibrozil; oral

4.8

45.7

102

213

FM1TQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT at rest and with exercise

9.2

45.6

ZXA00

NOMESCO Finland

Right side

1.5

45.3

1816

13208

SPAT1301

SPAT

No procedures

1.5

45.2

2148

16168

SPAT1255

SPAT

Intravenous administration of medicine

2.0

44.7

510

2638

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

44.4

4043

34279

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.6

44.2

146

410

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

44.2

203

698

N19

ICD-10 Finland

Unspecified kidney failure

2.5

44.0

286

1175

Z3226

NOMESCO Finland

Physiotherapist

1.6

43.8

1117

7329

A11CC03

ATC

alfacalcidol; systemic

3.3

43.7

165

505

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.7

43.6

236

886

N05BA04

ATC

oxazepam; oral

1.5

43.4

1563

11097

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

43.4

534

2834

C07AG02

ATC

carvedilol; oral

2.0

43.2

467

2368

E83.50

ICD-10 Finland

Hypercalcemia

6.7

43.2

102

A02BC01

ATC

omeprazole; systemic

1.5

43.0

1816

13325

C08CA02

ATC

felodipine; oral

1.8

42.9

750

4447

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

42.9

396

1892

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

3.8

42.6

132

355

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

3.5

42.4

148

431

C09CA03

ATC

valsartan; oral

1.8

42.1

681

3945

K92.1

ICD-10 Finland

Melaena

2.1

42.1

435

2169

E78.40

ICD-10 Finland

Familial combined hyperlipidaemia

68.9

42.0

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

41.9

915

5766

R02

ICPC

Shortness of breath/dyspnoea

1.7

41.6

849

5253

XCH00

NOMESCO Finland

Eye pressure measurement

2.1

41.4

388

1864

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.6

41.1

Multi-vessel balloon catheter extension

5.9

41.1

124

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

5.1

41.0

174

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

41.0

532

2874

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

40.7

2270

17535

WX892

NOMESCO Finland

Monitored bed care

1.9

40.6

504

2682

J01CA04

ATC

amoxicillin; systemic

1.5

40.5

4933

43693

C09BA02

ATC

enalapril and diuretics; systemic

1.8

40.3

635

3647

L03

ICPC

Low back symptom/complaint

1.5

40.3

1549

11124

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.5

40.3

138

397

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

40.3

1085

7201

AP1

Catheterization of the left side of the heart

3.5

40.2

141

412

B01AF02

ATC

apixaban; oral

1.6

40.1

976

6320

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

40.0

413

2058

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

40.0

556

3072

111

Conventional CABG

4.8

39.9

186

R07.2

ICD-10 Finland

Precordial pain

3.1

39.7

169

556

B04AC04, ,

ATC

5.4

39.3

147

P20

ICPC

Memory disturbance

1.6

39.2

1140

7698

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

39.1

673

3968

SPAT1153

SPAT

Removal of sutures

1.4

39.0

2185

16862

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

3.1

39.0

163

531

M10.0

ICD-10 Finland

Idiopathic gout

2.4

38.8

279

1200

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

38.8

531

2918

N05AH04

ATC

quetiapine; oral

1.6

38.7

904

5787

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

38.7

2920

23729

TK800

NOMESCO Finland

Hemodialysis

3.2

38.7

151

472

B04AD01, ,

ATC

11.5

38.7

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

38.6

957

6220

A10BD07

ATC

metformin and sitagliptin; systemic

2.3

38.6

312

1412

B04AC02, ,

ATC

6.7

38.6

XF404

NOMESCO Finland

Ambulatory ECG

1.8

38.4

597

3413

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.3

38.4

148

459

EBA00

NOMESCO Finland

Extraction of tooth

1.4

38.4

2060

15763

FL1AC

NOMESCO Finland

Left cardioangiography

3.3

38.3

149

465

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

38.2

342

1613

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

10.8

38.2

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

38.1

2550

20287

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

38.1

262

1105

162

Kela drug reimbursment

liraglutide

4.5

37.9

210

C08CA05

ATC

nifedipine; systemic

2.0

37.9

463

2449

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.2

37.9

148

463

AA2

Off pump CABG sternotomy

6.2

37.7

104

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.4

37.6

138

415

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.4

37.4

251

1047

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

37.3

161

534

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

37.3

2774

22444

J01AA02

ATC

doxycycline; systemic

1.4

37.2

4916

43767

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

37.1

3567

30096

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

36.9

287

1277

A10AB01

ATC

insulin (human); parenteral

2.7

36.8

195

724

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.1

36.6

157

519

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

36.6

639

3780

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

36.5

524

2923

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

5.9

36.4

111

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

36.3

995

6619

K78

ICPC

Atrial fibrillation/flutter

1.7

36.2

648

3860

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.8

36.0

112

302

A10AE06

ATC

insulin degludec; parenteral

2.7

36.0

191

710

Z71.8

ICD-10 Finland

Other specified counselling

1.5

36.0

1591

11712

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

35.9

329

1567

I20.10

ICD-10 Finland

Angina angiospastic

6.5

35.7

L17

ICPC

Foot/toe symptom/complaint

1.4

35.7

1720

12867

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

35.6

436

2307

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

35.6

786

4954

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

35.5

1289

9116

A02BC03

ATC

lansoprazole; oral

1.4

35.4

1824

13809

K02.1

ICD-10 Finland

Caries of dentine

1.4

35.4

3119

25869

C09AA04

ATC

perindopril; oral

2.0

35.4

390

1990

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.3

35.2

133

408

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

34.5

284

1294

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.8

34.5

177

647

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

34.3

1289

9177

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

34.3

268

1196

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

4.1

34.2

232

ZXD00

NOMESCO Finland

Emergency procedure

2.5

34.1

211

847

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

5.3

34.1

129

-1, ,

NOMESCO Finland

1.4

34.1

1679

12595

E66.9

ICD-10 Finland

Obesity, unspecified

2.7

34.0

183

685

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

34.0

326

1580

E78.21

ICD-10 Finland

Remnant hyperlipidemia

338.9

33.9

N06AB04

ATC

citalopram; systemic

1.5

33.8

1179

8261

A10BH02

ATC

vildagliptin; oral

2.8

33.5

168

606

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

6.1

33.5

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

33.5

423

2261

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.9

33.5

158

552

A10BX07

ATC

[U] liraglutide

4.0

33.4

245

WZC30

NOMESCO Finland

Teaching

1.6

33.3

974

6564

Z00.0

ICD-10 Finland

General medical examination

1.5

33.2

1217

8612

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

33.1

811

5242

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.8

33.1

104

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

32.9

644

3928

K76

ICPC

Ischaemic heart dis without angina

2.5

32.8

206

833

A11

ICPC

Chest pain NOS

1.8

32.7

524

3019

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.9

32.7

156

548

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

32.6

1617

12126

K28

ICPC

Limited function/disability (K)

2.7

32.6

184

706

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.4

32.6

185

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

7.2

32.6

Z50.1

ICD-10 Finland

Other physical therapy

2.0

32.5

347

1750

TFP20

NOMESCO Finland

Cardiodefibrillation

1.8

32.5

557

3275

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.5

32.4

174

2720X

ICD-9 Finland

Disorders of lipoid metabolism, Pure hypercholesterolaemia[HYPERCHOLESTEROLAEMIA ALIA]

+∞

32.3

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

32.2

1010

6910

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

32.2

306

1477

M03BX02

ATC

tizanidine; oral

1.4

32.2

3369

28544

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

32.0

967

6561

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.7

32.0

104

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

31.9

577

3442

A01

ICPC

Pain general/multiple sites

1.8

31.9

552

3252

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.5

31.9

197

790

KMAK, ,

NOMESCO Finland

1.4

31.9

2682

21964

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.8

31.9

258

G44.2

ICD-10 Finland

Tension-type headache

1.7

31.8

653

4034

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

31.8

934

6298

R4110

NOMESCO Finland

Physiotherapy

1.4

31.7

1598

12011

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.3

31.6

194

K84

ICPC

Heart disease other

2.4

31.5

216

910

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.2

31.5

272

1265

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

31.4

2067

16261

SPAT1236

SPAT

Informing family of child’s disability

2.8

31.4

161

588

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

31.4

744

4768

N18.0

ICD-10 Finland

End-stage renal disease

4.0

31.2

226

PD4AD

NOMESCO Finland

CT of lower extremity arteries

4.1

31.2

213

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

31.2

631

3883

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.9

31.1

140

A10AA01, ,

ATC

3.1

31.1

134

445

A10AA02, ,

ATC

2.5

31.0

198

807

XF409

NOMESCO Finland

Other special ECG

5.1

31.0

129

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

31.0

205

850

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

30.9

3865

33541

C10AC01

ATC

colestyramine; oral

2.6

30.8

184

726

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

30.7

2102

16636

H3601, E103,

ICD-10 Finland

6.1

30.6

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

30.5

457

2579

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

5.0

30.5

131

SPAT1104

SPAT

Monitoring of emergency patient

1.8

30.4

454

2560

A10BX04

ATC

[U] exenatide

4.3

30.4

187

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

30.3

1471

10969

A98

ICPC

Health maint/preventive medicine

1.6

30.3

6180

58156

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

30.2

1060

7421

N06AB10

ATC

escitalopram; oral

1.6

30.2

903

6109

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.4

30.1

108

321

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

30.0

612

3772

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.5

30.0

190

772

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

30.0

359

1885

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.0

29.9

350

1823

SFA10

NOMESCO Finland

One-surface restoration

1.3

29.9

2954

24710

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

29.8

254

1174

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

29.7

386

2083

R50.9

ICD-10 Finland

Fever, unspecified

1.5

29.6

890

6025

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.9

29.6

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

29.6

267

1264

A10BG03

ATC

pioglitazone; oral

2.5

29.4

186

755

A10BJ05

ATC

dulaglutide; parenteral

3.0

29.2

127

424

R60.0

ICD-10 Finland

Localized oedema

1.6

29.0

802

5328

R06.2

ICD-10 Finland

Wheezing

2.2

28.9

261

1235

I20.08

ICD-10 Finland

Unstable angina

8.8

28.9

N06AX16

ATC

venlafaxine; oral

1.7

28.9

615

3833

J01DA01

ATC

[U] cefalexin

1.3

28.9

3664

31723

C09DA06

ATC

candesartan and diuretics; oral

1.8

28.7

476

2768

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

28.7

375

2026

NHQ40

NOMESCO Finland

Amputation of toe

2.8

28.7

141

504

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

28.7

423

2376

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

28.6

437

2480

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.7

28.5

557

3392

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.7

28.4

156

591

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.0

28.3

202

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

28.2

2343

19050

A02BA02

ATC

ranitidine; systemic

1.4

28.0

1262

9267

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

28.0

184

761

R03BB04

ATC

tiotropium bromide; inhalant

1.6

28.0

727

4758

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

4.3

27.8

170

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

27.8

145

535

I50.1

ICD-10 Finland

Left ventricular failure

1.9

27.7

368

1999

E87.2

ICD-10 Finland

Acidosis

100.5

27.6

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

6.6

27.6

B01AC06

ATC

acetylsalicylic acid; oral

2.1

27.6

262

1265

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

2.3

27.6

210

927

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

27.6

198

852

K92

ICPC

Atherosclerosis/periph vascular dis

3.1

27.5

117

386

WVA30, ,

SPAT

1.9

27.5

350

1876

C09DA01

ATC

losartan and diuretics; oral

1.6

27.4

707

4619

N06AA09

ATC

amitriptyline; systemic

1.7

27.1

587

3671

H3600, E103,

ICD-10 Finland

5.2

27.1

106

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.8

27.1

125

J01CA08

ATC

pivmecillinam; oral

1.4

27.1

1959

15572

Z01.2

ICD-10 Finland

Dental examination

1.3

27.0

2307

18803

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.0

27.0

187

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

27.0

483

2871

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

26.9

859

5883

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

26.8

590

3705

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

26.8

303

1560

C01BD01

ATC

amiodarone; systemic

2.2

26.7

220

1004

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

26.5

340

1826

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

26.5

155

606

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.3

26.5

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

26.4

1989

15897

C08DB01

ATC

diltiazem; oral

1.8

26.3

394

2222

C10AX14

ATC

alirocumab; parenteral

29.3

26.2

SPAT1234

SPAT

Support of social functional capacity

1.8

26.2

383

2144

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

26.2

204

909

OAB50, ,

SPAT

1.9

26.2

345

1869

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.3

26.1

194

848

K77

ICPC

Heart failure

2.4

26.0

182

774

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

26.0

180

762

XF640, ,

NOMESCO Finland

2.3

26.0

201

893

PEN24

NOMESCO Finland

Plastic repair of deep femoral artery

5.9

26.0

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

26.0

480

2878

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.4

25.9

267

SPAT1260

SPAT

Consultation of another employee

1.5

25.8

1086

7860

XCK00

NOMESCO Finland

Perimetry

1.8

25.7

437

2559

A10AD05

ATC

insulin aspart; parenteral

2.7

25.7

142

540

R2110

NOMESCO Finland

Giving the first information

1.9

25.7

316

1674

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

25.7

660

4304

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

25.6

2125

17211

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.8

25.6

400

2285

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

25.6

437

2563

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

6.7

25.5

M25.5

ICD-10 Finland

Pain in joint

1.4

25.5

1603

12443

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

25.4

2259

18482

H3603, E113,

ICD-10 Finland

4.0

25.3

183

SPAT1081

SPAT

Cardiorespiratory global assessment

1.8

25.0

394

2257

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

24.9

184

802

SPAT1167

SPAT

Insertion of urinary catheter

2.0

24.9

260

1301

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

24.8

255

1268

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

24.8

357

1990

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

24.7

223

1056

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

2.7

24.7

135

511

SPAT1240

SPAT

Therapeutic discussion

1.8

24.6

411

2394

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

24.6

365

2053

A10AB06

ATC

insulin glulisine; parenteral

3.9

24.6

191

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

24.5

711

4767

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

24.4

1095

8011

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.2

24.4

C07AB08

ATC

celiprolol; oral

2.2

24.3

207

958

SPAT1059

SPAT

Spirometry at the office

1.9

24.2

324

1764

E0000UV, ,

ATC

1.3

24.2

2322

19166

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

3.3

24.2

279

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

24.1

1034

7500

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

5.7

24.1

K99

ICPC

Cardiovascular disease other

2.2

24.1

206

955

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

24.1

1031

7478

C09CA06

ATC

candesartan; oral

1.4

24.0

1333

10120

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.1

24.0

242

1196

SPAT1211

SPAT

Application of soft bandage

1.6

24.0

558

3552

R52.9

ICD-10 Finland

Pain, unspecified

1.6

23.9

533

3355

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

23.9

256

1292

FXZ00

NOMESCO Finland

Off-pump cardiac operation

4.2

23.9

147

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

23.8

1458

11250

H3601, E113,

ICD-10 Finland

2.9

23.7

114

403

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

3.8

23.7

187

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

23.5

566

3631

S06.0

ICD-10 Finland

Concussion

1.6

23.4

589

3819

A12AA04

ATC

calcium carbonate; oral

3.2

23.4

300

SPAT1285

SPAT

Provision of consultation response

1.8

23.4

335

1864

M01AH01

ATC

celecoxib; oral

1.4

23.4

1074

7887

-2, ,

ICPC

4.3

23.4

137

R4110, ,

SPAT

1.6

23.3

514

3226

T82

ICPC

Obesity

2.4

23.3

160

675

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

23.3

538

3418

Z2445

NOMESCO Finland

Psychologist

2.4

23.2

161

683

R04.0

ICD-10 Finland

Epistaxis

1.6

23.1

516

3249

R31

ICD-10 Finland

Unspecified haematuria

1.5

23.1

740

5063

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

4.4

23.1

130

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

23.0

318

1749

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

22.9

307

1672

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

7.4

22.9

XG466

NOMESCO Finland

Sleep oxymetry

2.2

22.8

196

910

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

22.8

189

865

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.1

22.8

212

1016

C02EA02, ,

ATC

1.8

22.8

339

1909

K01

ICPC

Heart pain

2.9

22.7

103

353

I95.9

ICD-10 Finland

Hypotension, unspecified

2.8

22.5

116

426

H03AA01

ATC

levothyroxine sodium; systemic

1.4

22.5

1205

9083

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

2.9

22.5

108

382

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.0

22.5

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

22.5

410

2449

M01AX17

ATC

nimesulide; oral

1.4

22.5

1517

11871

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

22.4

640

4271

N02BF02

ATC

pregabalin; oral

1.9

22.4

302

1649

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

22.4

1447

11246

J01EA01

ATC

trimethoprim; systemic

1.4

22.3

1442

11204

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.5

22.3

134

532

SPAT1251

SPAT

Organisation of medication

2.0

22.2

234

1175

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.7

22.2

187

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.1

22.1

214

1042

L15

ICPC

Knee symptom/complaint

1.4

22.1

1341

10318

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.4

22.0

149

626

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

21.9

135

542

K74

ICPC

Ischaemic heart dis with angina

2.9

21.9

100

344

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.8

21.9

175

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.2

21.9

140

J01FA06

ATC

roxithromycin; oral

1.3

21.9

2244

18630

P03

ICPC

Feeling depressed

1.8

21.8

328

1852

SPAT1053

SPAT

Memory test

1.4

21.8

1164

8763

R4120

NOMESCO Finland

Occupational therapy

1.8

21.8

329

1860

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

21.8

904

6511

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

8.1

21.7

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.7

21.7

185

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

21.7

353

2041

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

21.7

253

1317

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.2

21.6

137

B01AC22

ATC

prasugrel; oral

5.7

21.6

B04AB03, ,

ATC

8.7

21.5

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

21.5

405

2440

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.3

21.5

162

713

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

21.4

448

2774

ZPB22

NOMESCO Finland

Autograft of vein

4.3

21.3

126

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.2

21.2

271

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

4.4

21.2

118

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

21.2

422

2580

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

21.2

466

2923

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

21.2

126

498

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

6.1

21.1

E66.0

ICD-10 Finland

Obesity due to excess calories

3.4

21.0

218

L13

ICPC

Hip symptom/complaint

1.4

21.0

1095

8209

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.8

21.0

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.2

21.0

268

N05AX08

ATC

risperidone; systemic

1.6

20.9

516

3331

Z2221

NOMESCO Finland

Medical doctor

1.3

20.8

1457

11444

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

20.8

706

4886

R52.2

ICD-10 Finland

Other chronic pain

2.1

20.7

195

940

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.4

20.6

144

613

G04CA02

ATC

tamsulosin; oral

1.3

20.6

1874

15280

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.4

20.6

138

577

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

4.7

20.5

101

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.7

20.4

170

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

3.6

20.3

189

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.8

20.3

157

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

20.2

325

1873

SPAT1172

SPAT

Guidance concerning hydration

2.1

20.2

182

862

WW500

NOMESCO Finland

Blood transfusion

1.9

20.2

253

1349

SFA20

NOMESCO Finland

Two-surface restoration

1.3

20.2

2980

25825

C07BB07

ATC

bisoprolol and thiazides; systemic

1.9

20.2

255

1364

I20.0

ICD-10 Finland

Unstable angina

3.5

20.1

200

WX320

NOMESCO Finland

Spinalanesthesy

1.3

20.1

1475

11662

G63.2

ICD-10 Finland

Diabetic polyneuropathy

4.8

20.1

PD5AD

NOMESCO Finland

CT of aorta

2.3

20.0

151

665

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.5

20.0

196

N03AX09

ATC

lamotrigine; oral

2.2

20.0

169

781

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

3.5

19.9

201

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2.5

19.9

120

478

2722A

ICD-9 Finland

Disorders of lipoid metabolism, Mixed hyperlipidaemia

+∞

19.8

D07AC01

ATC

betamethasone; topical

1.3

19.8

2072

17194

N18

ICPC

Paralysis/weakness

2.4

19.8

140

600

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

19.8

532

3501

SPAT1360

SPAT

Extensive global examination

1.6

19.8

450

2847

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

19.8

571

3818

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

19.7

489

3157

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.1

19.7

196

964

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

19.6

262

1428

WX290

NOMESCO Finland

Other blockage of nerve

1.3

19.6

2084

17327

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

19.5

314

1810

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

19.5

938

6927

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.8

19.5

157

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

19.5

262

1430

A10BG02

ATC

rosiglitazone; oral

2.6

19.4

109

419

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.6

19.4

181

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

19.3

401

2478

A10BD03

ATC

metformin and rosiglitazone; systemic

2.5

19.3

117

467

A99

ICPC

Disease/condition unspecnature/site

1.5

19.3

539

3577

A10BJ01

ATC

exenatide; parenteral

3.5

19.3

191

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.5

19.3

120

485

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.2

19.3

123

PD3BT

NOMESCO Finland

Pelvic artery extensive PTA

6.3

19.2

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

19.2

1106

8420

PD3AT

NOMESCO Finland

Pelvic artery PTA

4.3

19.1

111

E11.09

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - With coma

5.9

19.1

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.7

19.1

N05CD07

ATC

temazepam; oral

1.4

19.1

766

5474

R33

ICD-10 Finland

Retention of urine

1.5

19.1

581

3929

CLA10, ,

SPAT

7.2

19.1

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

7.2

19.1

XG405

NOMESCO Finland

Education on PEF monitoring

2.8

19.0

355

S22.3

ICD-10 Finland

Fracture of rib

1.6

19.0

421

2645

R5110, ,

SPAT

1.7

18.9

390

2407

I70.0

ICD-10 Finland

Atherosclerosis of aorta

4.1

18.9

125

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

3.4

18.8

194

K30

ICD-10 Finland

Functional dyspepsia

1.5

18.8

555

3727

M01AB05

ATC

diclofenac; systemic, rectal

1.3

18.8

3802

34079

K07

ICPC

Swollen ankles/oedema

1.8

18.7

311

1809

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

18.7

2213

18619

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

4.1

18.7

126

K22

ICPC

Risk factor cardiovascular disease

1.7

18.7

374

2291

C09CA07

ATC

telmisartan; oral

1.6

18.6

437

2786

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

18.6

163

765

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

18.6

264

1467

H02AB07

ATC

prednisone; oral

1.4

18.5

787

5685

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

18.4

207

1064

Z51.88

ICD-10 Finland

Other specified medical care

2.3

18.4

134

582

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.0

18.3

187

929

SPAT1281

SPAT

Other administrative function

1.6

18.3

445

2859

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.3

18.2

133

578

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.3

18.2

107

C07AB03

ATC

atenolol; systemic

1.6

18.2

406

2555

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

5.9

18.2

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

7.1

18.2

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.8

18.2

142

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.8

18.1

288

1654

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.1

18.1

169

812

WX199

NOMESCO Finland

Other local analgesia

1.9

18.1

221

1169

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

18.0

119

495

V03AE02

ATC

sevelamer; oral

4.9

18.0

N02BF01

ATC

gabapentin; oral

1.6

18.0

411

2602

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

17.9

519

3470

R10.0

ICD-10 Finland

Acute abdomen

2.1

17.9

170

822

Z2446

NOMESCO Finland

Social worker

1.7

17.9

320

1902

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

17.8

166

797

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

17.8

411

2608

E83.51

ICD-10 Finland

Hypocalcemia

18.1

17.7

TK810

NOMESCO Finland

Hemofiltration

4.4

17.7

101

B01AF01

ATC

rivaroxaban; oral

1.4

17.7

863

6381

C08CA07

ATC

nisoldipine; oral

2.7

17.7

363

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.5

17.7

108

433

S29

ICPC

Skin symptom/complaint other

1.4

17.7

1093

8403

I47.2

ICD-10 Finland

Ventricular tachycardia

2.3

17.6

136

606

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

36.8

17.6

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.5

17.5

502

3349

R03BA05

ATC

fluticasone; inhalant

1.4

17.5

913

6828

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.1

17.5

173

850

A10BB01

ATC

glibenclamide; oral

1.8

17.5

290

1687

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

4.7

17.5

ACC51

NOMESCO Finland

Release of median nerve

1.6

17.5

371

2307

L04AD02

ATC

tacrolimus; systemic

4.0

17.4

124

I95.2

ICD-10 Finland

Hypotension due to drugs

3.5

17.4

170

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.9

17.4

272

H26.4

ICD-10 Finland

After-cataract

1.4

17.4

714

5122

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

2.5

17.3

112

461

A10AD01

ATC

insulin (human); parenteral

2.5

17.3

110

449

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

17.3

222

1194

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

2.7

17.3

350

K91

ICPC

Cerebrovascular disease

2.6

17.3

379

-69

ICPC

Other reason for encounter NEC

1.9

17.3

233

1274

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.5

17.3

541

3679

E78.8

ICD-10 Finland

Other disorders of lipoprotein metabolism

20.9

17.3

F21, ,

ICPC

3.0

17.3

257

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.7

17.2

302

1784

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

17.2

697

4984

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

17.2

2201

18645

SFA30

NOMESCO Finland

Three-surface restoration

1.3

17.2

2211

18740

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

17.2

1378

10997

CKC12

NOMESCO Finland

Photocoagulation of retina

1.8

17.2

241

1334

L14

ICPC

Leg/thigh symptom/complaint

1.6

17.0

445

2909

M01AH02

ATC

rofecoxib; oral

1.4

17.0

789

5786

ZPB96

NOMESCO Finland

Other material in vessel transplant

6.9

17.0

R47.0

ICD-10 Finland

Dysphasia and aphasia

3.0

17.0

249

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

16.9

500

3358

H02AB04

ATC

methylprednisolone; systemic

1.4

16.9

778

5696

C03BA11

ATC

indapamide; oral

2.0

16.9

184

937

SPAT1359

SPAT

Use of symptom diary

2.1

16.8

155

742

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

16.8

161

782

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.1

16.8

114

C10AA06

ATC

cerivastatin; oral

4.5

16.8

PD1AE

NOMESCO Finland

Ultrasound examination of abdominal aortta

3.3

16.7

189

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

5.2

16.7

R06.5

ICD-10 Finland

Mouth breathing

1.6

16.7

449

2953

H53.4

ICD-10 Finland

Visual field defects

2.3

16.7

130

582

A12BA01

ATC

potassium chloride; oral

1.7

16.6

299

1779

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

16.6

314

1895

ZPB40

NOMESCO Finland

Polytetrafluoroethylene

4.9

16.6

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.6

16.5

347

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.1

16.5

216

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

16.5

713

5160

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

16.5

722

5238

R4180, ,

SPAT

3.1

16.4

227

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.7

16.4

143

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

16.4

735

5352

PG2YT

NOMESCO Finland

Implantation of arterial endoprothesis not elsewhere classified

13.4

16.4

WZC30, ,

SPAT

1.7

16.4

312

1887

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

16.2

728

5303

I49.5

ICD-10 Finland

Sick sinus syndrome

1.7

16.2

279

1641

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

16.2

1332

10659

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

16.2

391

2510

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

16.1

685

4941

I20.19

ICD-10 Finland

Angina angiospastic

4.9

16.1

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

16.1

160

788

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

2.7

16.1

323

A03

ICPC

Fever

1.4

16.1

686

4951

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

7.1

16.1

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

4.5

16.1

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

16.0

352

2207

M01AE02

ATC

naproxen; oral, rectal

1.2

16.0

3016

26619

A10BX02

ATC

repaglinide; oral

2.6

16.0

347

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.5

16.0

160

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

3.6

16.0

146

Z94.0

ICD-10 Finland

Kidney transplant status

3.3

15.9

180

R01AD09

ATC

mometasone; nasal

1.3

15.9

2192

18694

C09DA03

ATC

valsartan and diuretics; oral

1.7

15.9

302

1825

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.8

15.9

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.3

15.8

117

512

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

15.8

585

4112

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.7

15.8

306

1859

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

15.8

1739

14444

N06AB06

ATC

sertraline; oral

1.5

15.7

466

3131

H3600, E113,

ICD-10 Finland

2.7

15.7

310

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.7

15.7

292

1754

127

Kela drug reimbursment

Transplant complication

2.9

15.7

255

C09DA07

ATC

telmisartan and diuretics; oral

1.8

15.7

239

1358

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

4.9

15.6

BEF00, ,

SPAT

4.0

15.6

107

ZXA10

NOMESCO Finland

Bilateral

1.3

15.6

1109

8690

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

5.3

15.6

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.9

15.5

200

1078

FM3CN

NOMESCO Finland

Heart perfusion isotope imaging both at rest and with exercise

5.6

15.5

SPAT1312

SPAT

General health counselling

1.3

15.5

1775

14803

Z00.8

ICD-10 Finland

Other general examinations

1.6

15.5

387

2503

D07AC13

ATC

mometasone; topical

1.3

15.5

1560

12808

M79.1

ICD-10 Finland

Myalgia

1.4

15.5

647

4653

H05BX01

ATC

cinacalcet; oral

4.0

15.4

108

R52.1

ICD-10 Finland

Chronic intractable pain

3.3

15.4

169

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

15.4

317

1956

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.4

15.4

105

444

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

15.4

170

871

G45.3

ICD-10 Finland

Amaurosis fugax

2.2

15.3

124

564

WX002

NOMESCO Finland

Sedation and analgesia

1.3

15.3

1116

8775

FNC50

NOMESCO Finland

Aorto-coronary venous bypass with five distal anastomoses

6.7

15.3

H53.2

ICD-10 Finland

Diplopia

1.9

15.2

177

922

N03AX14

ATC

levetiracetam; systemic

2.1

15.2

149

730

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

15.2

312

1923

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.5

15.2

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.0

15.2

162

819

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

15.2

268

1587

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.2

15.2

126

579

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.7

15.1

M54.3

ICD-10 Finland

Sciatica

1.7

15.1

308

1896

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

15.1

724

5333

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

15.1

332

2083

I63.8

ICD-10 Finland

Other cerebral infarction

3.0

15.1

228

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

15.1

279

1674

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.4

15.1

104

442

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.3

15.0

115

511

R05

ICD-10 Finland

Cough

1.3

15.0

1122

8850

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

15.0

621

4456

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

15.0

573

4051

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

15.0

603

4305

AB2

AVR bio, stent

3.3

15.0

172

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.8

14.9

251

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

14.9

342

2168

FWW96

NOMESCO Finland

Other reoperation on heart or major thoracic vessels

5.8

14.9

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.6

14.9

316

1965

R29

ICPC

Respiratory symptom/complaint other

1.6

14.9

330

2075

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

14.9

1216

9711

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.1

14.8

132

624

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.6

14.8

337

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

14.8

638

4611

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

14.8

190

1023

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

14.8

338

2142

WZA00

NOMESCO Finland

Concise certificate

1.7

14.7

293

1792

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

3.3

14.7

169

FM1CR

NOMESCO Finland

Heart perfusion PET with TT

4.4

14.7

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

14.7

240

1392

A06AC51

ATC

ispaghula, combinations; oral

1.7

14.7

271

1626

XPX00

NOMESCO Finland

Intraoperative angiography

4.1

14.6

27200

ICD-8 Finland

Congenital disorders of lipid metabolism, Hypercholesterolaemia essentialis sive familiaris

+∞

14.6

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

14.6

356

2291

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

14.6

153

770

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.6

14.5

331

2095

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

14.5

591

4228

J01MA14

ATC

moxifloxacin; systemic

1.5

14.5

497

3442

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

3.7

14.5

118

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

5.8

14.4

G04CB01

ATC

finasteride; oral

1.3

14.4

891

6833

R06.4

ICD-10 Finland

Hyperventilation

2.7

14.4

284

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

14.4

2198

18906

N03AG01

ATC

valproic acid; systemic, rectal

1.7

14.4

273

1649

R03AC03

ATC

terbutaline; inhalant

1.4

14.4

676

4961

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

14.4

1304

10552

N17

ICPC

Vertigo/dizziness

1.4

14.4

694

5117

PA6AD

NOMESCO Finland

CT of neck arteries

2.0

14.3

154

781

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

14.3

224

1282

A87

ICPC

Complication of medical treatment

3.2

14.3

177

A08

ICPC

Swelling

1.6

14.3

296

1830

J45.8

ICD-10 Finland

Mixed asthma

1.9

14.3

168

880

K59.0

ICD-10 Finland

Constipation

1.6

14.3

328

2081

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

14.2

156

798

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

14.2

1404

11485

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.4

14.2

405

FN1AD

NOMESCO Finland

CT of coronary arteries

2.5

14.1

351

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.6

14.1

356

2308

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

14.1

975

7601

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

14.1

1352

11014

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.4

14.1

412

PFH59

NOMESCO Finland

Bypass from femoral or popliteal artery to distal anterior tibial artery

6.4

14.1

P76

ICPC

Depressive disorder

1.8

14.0

211

1194

L08

ICPC

Shoulder symptom/complaint

1.3

14.0

1176

9417

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

14.0

161

837

X58

ICD-10 Finland

Exposure to other specified factors

1.4

14.0

674

4968

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.0

13.9

157

810

TQW80

NOMESCO Finland

Local dermatologic skincare

2.0

13.9

159

824

I20

ICD-10 Finland

Angina pectoris

2.4

13.9

409

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

13.9

552

3933

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

13.8

199

1112

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

13.8

955

7444

A10BX09

ATC

[U] dapagliflozin

3.1

13.8

181

B03XA02

ATC

darbepoetin alfa; parenteral

2.2

13.8

119

556

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

13.8

163

855

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

13.8

372

2450

PEQ23

NOMESCO Finland

Insertion of endovascular graft into femoral artery

23.8

13.8

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

13.7

2004

17135

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

5.7

13.7

Z51.5

ICD-10 Finland

Palliative care

1.4

13.6

537

3818

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

13.6

210

1198

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

13.6

157

817

C01AA05

ATC

digoxin; systemic

1.4

13.6

571

4108

N05BA01

ATC

diazepam; systemic, rectal

1.4

13.6

691

5138

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.8

13.6

197

1104

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.1

13.5

118

554

SPAT1284

SPAT

Extensive health certificate

2.0

13.5

136

674

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

2.5

13.5

317

ZXD20

NOMESCO Finland

Day surgery

1.4

13.5

642

4719

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

2.4

13.5

396

WX890

NOMESCO Finland

Intesive care monitoring

3.1

13.4

179

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022217) INR in Platelet poor plasma by Coagulation assay

4412

28047

2.59

303.10

21.6

17.4

1.35

inr

0.16

1251

7881

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3250

18265

2.47

286.70

4.0

2.9

1774.65

1503.28

ng/l

2.87

2879

15705

(3013826) Glucose [Moles/volume] in Serum or Plasma

4737

32992

2.39

237.68

6.5

4.3

7.21

6.78

mmol/l

29.34

4573

30825

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2926

16707

2.30

236.39

2.7

2.0

200.44

234.74

u/l

1.18

2780

15472

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3567

22461

2.22

222.78

5.8

3.5

67.56

76.35

ng/l

0.16

2885

16947

(3009343) pH of Capillary blood

985

3511

3.11

207.51

4.3

3.4

7.41

7.42

1.36

422

(3020682) Albumin/Creatinine [Ratio] in Urine

3028

18252

2.17

206.43

4.6

3.6

12.09

7.11

mg/mmol

5.92

2071

11228

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

992

3569

3.08

205.52

4.3

3.4

5.13

5.17

kpa

0.70

937

3348

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

950

3407

3.07

197.50

4.2

3.3

1.61

1.91

mmol/l

1.52

717

2543

(3012516) Albumin [Mass/volume] in Urine

2864

17310

2.12

189.48

3.9

3.1

286.48

351.61

mg/l

0.39

2002

10904

(3009508) Creatinine [Moles/volume] in Urine

2914

17730

2.11

189.39

3.9

3.0

7.14

7.53

mmol/l

5.78

2416

14470

(3022313) Gas panel - Capillary blood

779

2612

3.23

180.88

4.4

3.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

837

2996

3.04

173.49

4.0

2.6

0.35

0.31

e6/l

0.20

820

2933

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4094

28956

2.02

168.34

6.4

6.1

11.98

12.26

umol/l

0.58

3929

27355

(3023368) Bacteria identified in Blood by Culture

2665

16387

2.02

161.57

4.9

4.1

—

(3044640) Blood type and Crossmatch panel - Blood

2790

17450

2.00

161.04

3.0

2.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2764

17338

1.99

157.23

3.2

2.4

58.66

62.52

u/l

1.38

2622

15849

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3642

25466

1.91

146.43

3.2

2.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

437

1228

3.73

132.66

4.6

3.5

26.29

31.35

mg/l

1.87

324

772

(3040151) Glucose [Moles/volume] in Capillary blood

293

616

4.92

130.33

19.7

16.2

7.93

7.17

mmol/l

2.45

243

496

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2455

15551

1.90

129.31

3.3

3.1

36.47

35.16

u/l

0.30

2334

14535

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1311

6703

2.18

125.60

8.0

4.8

1.08

1.02

mmol/l

7.45

1219

6135

(3020779) Urea [Moles/volume] in Serum or Plasma

1032

4786

2.36

125.01

9.3

5.7

11.54

10.30

mmol/l

5.26

973

4507

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5303

43073

1.99

123.75

8.9

7.3

83.31

80.03

u/l

3.28

5043

40070

(3031040) Bacteria [#/volume] in Urine by Automated count

4731

37146

1.87

120.63

6.6

4.6

1617.85

2315.97

e6/l

0.62

336

500

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1493

8251

2.03

115.30

2.2

1.9

30.27

30.01

0.73

1454

7982

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3866

28778

1.78

115.19

9.4

5.8

1.21

mmol/l

0.03

3425

24009

(3000850) Epithelial cells [#/volume] in Urine

2014

12419

1.88

112.01

3.5

2.5

5.02

4.67

e6/l

0.76

1863

11002

(3015235) Bicarbonate [Moles/volume] in Capillary blood

435

1365

3.33

111.14

3.8

2.9

24.66

25.06

mmol/l

1.10

426

1336

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1088

5461

2.18

107.78

3.0

2.3

6.72

7.38

ug/l

0.54

925

4709

(3002582) Erythrocytes [#/volume] in Urine

2582

17388

1.77

106.16

4.5

3.2

64.15

101.33

e6/l

1.31

2174

13434

(3026493) Urate [Moles/volume] in Serum or Plasma

2245

14516

1.81

105.92

3.4

2.7

4584.49

5447.48

umol/l

0.39

1944

12337

(3022948) Iron [Moles/volume] in Serum or Plasma

1490

8465

1.97

105.20

3.3

2.3

11.56

12.57

umol/l

7.12

1393

7763

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6146

53697

2.31

104.10

24.0

14.7

26.95

26.73

mg/l

0.19

5439

42823

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3334

24235

1.73

103.77

2.3

2.0

95.81

93.52

pmol/l

1.68

1809

12565

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5874

50484

2.09

102.88

9.2

5.9

44.12

40.12

mmol/mol

134.08

5449

45402

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1774

10773

1.87

101.89

5.5

3.6

361.43

536.56

ng/l

0.94

1491

9015

(3018095) Leukocytes [#/volume] in Urine

2840

19822

1.73

101.76

5.1

3.6

137.21

112.48

e6/l

0.56

2271

14424

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5826

50066

2.04

99.85

5.9

4.0

1.49

1.25

mmol/l

80.24

5354

44221

(3027945) Reticulocytes/100 erythrocytes in Blood

1253

6814

2.02

99.63

3.0

2.4

1.85

1.74

3.51

1116

5955

(3024561) Albumin [Mass/volume] in Serum or Plasma

3350

24560

1.71

99.57

5.6

4.5

34.17

34.89

g/l

9.49

3127

22564

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2197

14330

1.78

99.28

2.5

2.2

3.21

3.09

mg/l

1.49

1891

12069

(3037467) Urinalysis macro (dipstick) panel - Urine

4729

38111

1.76

99.17

5.7

4.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

584

2309

2.67

98.41

5.0

3.6

24.68

24.96

mmol/l

1.24

536

2101

(3028626) Oxygen [Partial pressure] in Capillary blood

385

1220

3.28

96.62

3.0

7.75

7.99

kpa

2.12

374

1191

(3002030) Lymphocytes/100 leukocytes in Blood

3397

25131

1.69

96.50

6.3

5.9

25.23

26.66

10.45

3168

23224

(3018010) Neutrophils/100 leukocytes in Blood

3346

24713

1.69

95.16

6.0

5.7

59.56

58.11

9.25

3116

22821

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

584

2358

2.61

94.21

2.1

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1367

7802

1.94

93.97

3.3

2.2

2.29

2.27

g/l

0.44

1269

7109

(3019069) Monocytes/100 leukocytes in Blood

3327

24617

1.68

93.30

6.6

6.1

8.76

8.87

1.08

3101

22686

(3006504) Eosinophils/100 leukocytes in Blood

3308

24451

1.68

93.05

6.2

5.8

2.82

2.86

0.43

3075

22498

(3013707) Erythrocyte sedimentation rate by Westergren method

4898

40205

1.75

92.47

4.9

4.0

15.82

13.31

mm/h

19.38

4541

36451

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

618

2592

2.52

92.06

2.2

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1573

9481

1.85

91.01

2.1

1.8

—

(3022096) Basophils/100 leukocytes in Blood

3216

23696

1.67

90.78

6.2

5.8

0.61

0.66

5.58

2986

21790

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1296

7344

1.94

90.66

3.4

2.3

20.29

22.24

5.99

1136

6119

(3013115) Eosinophils [#/volume] in Blood

3570

27110

1.66

88.86

6.0

5.7

0.21

0.20

e9/l

1.51

3189

23518

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3472

26206

1.65

88.30

8.3

5.2

1.21

mmol/l

0.15

3164

23407

(3013650) Neutrophils [#/volume] in Blood by Automated count

3935

30819

1.64

85.06

8.7

4.59

4.22

e9/l

15.05

3527

26776

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

399

1394

2.98

84.63

2.4

2.1

133.26

85.45

ug/min

1.21

270

777

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2034

13489

1.72

83.76

3.0

2.4

—

(3021901) Oxygen saturation in Capillary blood

321

994

3.34

83.50

2.9

2.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2818

20380

1.65

83.24

3.4

2.6

156.83

161.35

ug/l

0.30

2579

18334

(3019309) Folate [Moles/volume] in Red Blood Cells

1879

12215

1.74

83.02

1.9

1.7

1141.86

1165.15

nmol/l

0.51

1495

8995

(3013512) EKG study

2553

18025

1.66

82.77

6.0

3.9

—

(3016502) Oxygen saturation in Arterial blood

1080

5920

1.98

82.57

7.2

6.7

94.58

95.44

3.41

1059

5678

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5612

48500

1.84

82.15

5.4

4.4

2.03

2.11

mu/l

0.76

5101

42863

(3006315) Basophils [#/volume] in Blood

3449

26280

1.62

82.14

5.8

5.5

0.04

e9/l

0.04

3052

22497

(3019550) Sodium [Moles/volume] in Serum or Plasma

6331

57066

2.31

81.72

29.2

17.0

139.50

139.73

mmol/l

9.70

6225

55367

(3001604) Monocytes [#/volume] in Blood

3436

26192

1.62

81.41

5.8

5.5

0.65

0.61

e9/l

10.25

3035

22413

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5943

52355

1.97

81.27

6.4

4.5

4.21

4.56

mmol/l

107.08

5555

47060

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5826

50993

1.91

81.20

22.3

13.9

71.57

75.39

ml/min/173m2

30.74

4825

42110

(3019198) Lymphocytes [#/volume] in Blood

3509

26898

1.62

81.15

5.9

5.5

1.90

1.91

e9/l

0.14

3189

23541

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2909

21303

1.63

81.07

2.4

2.1

76.68

79.84

nmol/l

7.37

2553

18419

(3023103) Potassium [Moles/volume] in Serum or Plasma

6334

57195

2.29

79.84

29.4

17.1

4.02

3.99

mmol/l

15.24

6219

55393

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5894

51855

1.93

79.82

6.5

4.4

1.32

1.46

mmol/l

123.53

5447

46260

(3003396) Base excess in Arterial blood by calculation

1157

6573

1.91

79.29

7.0

6.4

1.32

1.13

mmol/l

0.86

903

5173

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6053

53787

2.01

78.81

7.0

5.0

2.36

2.68

mmol/l

116.61

5617

48052

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3976

31548

1.61

78.66

4.1

3.0

68.72

52.93

u/l

9.39

3726

28490

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

108

142

7.71

77.15

1.5

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

108

142

7.71

77.15

1.5

2.0

—

(3019150) Specific gravity of Urine by Refractometry

1840

12097

1.71

77.03

5.3

4.3

1.02

kg/l

1.31

358

1819

(3026008) Bacteria identified in Urine by Culture

2501

17857

1.63

75.79

3.8

3.2

—

(3022621) pH of Urine by Test strip

749

3716

2.14

74.74

3.5

3.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4686

39005

1.63

73.38

4.2

3.7

14.95

15.03

pmol/l

1.43

4223

34300

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1913

12878

1.67

72.48

1.8

1.7

41827602.15

29774459.75

pmol/l

0.28

1609

10311

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

550

2436

2.37

72.16

2.1

1.9

2.47

2.60

ug/l

0.09

488

2102

(3042936) Bacteria identified in Isolate by Culture

1298

7877

1.80

71.29

2.4

1.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5931

52902

1.85

68.29

6.4

4.8

6.44

6.02

mmol/l

74.37

5390

46756

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1370

8579

1.74

67.06

3.5

3.0

0.81

0.82

mmol/l

3.23

1289

7944

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6283

57271

2.07

65.64

14.0

10.4

26.96

25.48

u/l

6.78

6095

54482

(40760892) CBC W Ordered Manual Differential panel - Blood

3177

24552

1.54

65.47

6.4

6.2

—

(3019225) pH of Specimen

1081

6380

1.82

64.51

6.4

3.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

676

3416

2.09

63.84

1.8

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1634

10902

1.65

62.54

1.8

1.6

1.31

1.40

mg/l

0.54

1302

8393

(3009261) Glucose [Presence] in Urine by Test strip

3401

26846

1.53

62.43

4.8

3.8

0.00

estimate

0.16

490

4939

(3035350) Ketones [Presence] in Urine by Test strip

3362

26539

1.52

61.25

4.8

3.8

0.00

estimate

1.79

556

5465

(3019977) pH of Arterial blood

141

303

4.73

61.01

1.6

2.3

7.43

0.07

129

(3021601) Nitrite [Presence] in Urine by Test strip

3348

26478

1.51

59.97

6.2

5.0

0.00

estimate

0.80

530

5048

(3044242) Glucose [Moles/volume] in Arterial blood

129

261

5.02

59.94

1.5

1.9

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1094

6615

1.78

59.80

7.3

6.4

11.48

12.05

kpa

3.11

1054

6269

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1094

6617

1.78

59.73

7.3

6.4

5.12

5.08

kpa

0.43

1056

6282

(3002032) Base excess in Venous blood by calculation

877

5012

1.86

57.59

4.5

3.4

1.90

1.96

mmol/l

0.18

742

4202

(3014111) Lactate [Moles/volume] in Serum or Plasma

846

4785

1.88

57.39

6.4

6.0

1.46

1.39

mmol/l

0.72

831

4642

(3021960) Folate [Moles/volume] in Serum or Plasma

1962

14002

1.56

55.54

1.7

1.5

18.74

20.40

nmol/l

4.83

1635

11666

(3007853) Bacteria identified in Skin by Aerobe culture

1048

6424

1.74

54.17

2.1

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

432

1957

2.29

53.45

2.3

2.1

584.21

604.16

ug/l

0.04

415

1852

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

702

3819

1.93

53.44

5.5

3.3

115.83

89.72

ng/l

6.17

604

3193

(3012544) pH of Venous blood

886

5205

1.81

52.91

4.4

3.4

7.38

—

(3009542) Hematocrit [Volume Fraction] of Blood

6380

59205

2.01

52.13

35.2

21.9

39.20

40.00

9.87

6063

54553

(3007461) Platelets [#/volume] in Blood

6381

59235

2.01

51.82

35.2

21.8

238.91

240.82

e9/l

1.51

6262

57312

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

891

5274

1.79

51.81

3.3

2.7

258.19

227.76

ng/l

0.83

831

4797

(3024731) MCV [Entitic volume]

6381

59248

2.01

51.58

35.0

21.7

91.54

91.59

0.34

6304

58033

(3000963) Hemoglobin [Mass/volume] in Blood

6382

59262

2.01

51.55

35.4

21.9

131.53

134.89

g/l

51.92

6301

58055

(3010813) Leukocytes [#/volume] in Blood

6381

59252

2.00

51.51

35.2

21.8

7.25

6.80

e9/l

23.88

6245

57088

(3026361) Erythrocytes [#/volume] in Blood

6380

59253

2.00

51.26

35.2

21.8

4.37

4.45

e12/l

32.86

6240

57110

(3035941) MCH [Entitic mass]

6379

59246

2.00

51.17

35.0

21.7

30.33

30.46

7.18

6301

58029

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1191

7691

1.66

50.42

6.2

4.5

33.23

32.92

0.43

871

5000

(3041096) Erythrocytes [Presence] in Urine by Automated

1890

13611

1.53

50.40

4.5

3.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

680

3737

1.91

50.07

8.0

6.7

24.63

24.62

mmol/l

0.01

666

3547

(3021447) Carbon dioxide [Partial pressure] in Venous blood

853

5045

1.79

49.60

4.6

3.4

5.80

5.83

kpa

0.32

835

4892

(40761511) CBC panel - Blood by Automated count

6043

55337

1.73

48.84

23.2

14.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

701

3954

1.86

47.50

1.7

1.6

—

(3015736) pH of Urine

2706

21151

1.46

47.50

4.5

3.5

5.75

5.80

0.17

1001

(3037121) Protein [Mass/volume] in Urine

407

1916

2.19

45.77

3.9

2.9

0.42

0.28

g/l

2.50

198

755

(3002173) Hemoglobin [Mass/volume] in Arterial blood

882

5384

1.73

45.70

8.1

7.1

119.58

121.09

g/l

1.33

877

5215

(4146454) Self-monitoring of blood glucose

192

632

3.10

45.07

2.9

2.5

—

(40768797) Stomach Pathology biopsy report

1118

7291

1.64

45.04

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2638

20679

1.45

44.83

5.1

4.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

674

3823

1.85

44.76

2.3

381.48

366.99

nmol/l

1.09

613

3476

(3023520) Reticulocytes [#/volume] in Blood

854

5200

1.73

44.58

2.6

72.10

67.49

e9/l

3.38

705

4017

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

355

1601

2.28

44.29

1.4

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

603

3341

1.88

43.06

1.6

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

521

2766

1.96

42.30

4.3

3.0

24.92

25.18

mmol/l

0.89

504

2688

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

502

2637

1.97

42.02

1.7

1.6

1.68

1.54

g/l

2.35

416

2228

(3000991) Gas panel - Venous blood

751

4480

1.76

42.02

8.6

7.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

908

5740

1.67

41.03

3.0

2.6

9.61

9.93

umol/l

0.14

794

4999

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

117

299

3.96

40.55

1.3

1.2

8.86

9.41

mmol/l

0.60

112

280

(3049717) Cytology report of Urine Cyto stain

502

2699

1.93

39.19

3.0

2.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3138

25785

1.40

39.09

2.6

2.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

687

4099

1.75

38.25

2.5

2.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

697

4204

1.73

37.30

3.8

2.8

4.80

4.44

kpa

3.54

683

4061

(3020630) Protein [Mass/volume] in Serum or Plasma

792

4951

1.68

37.13

2.8

2.4

65.70

66.37

g/l

1.60

730

4386

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

810

5121

1.66

36.32

2.2

0.20

g/l

0.27

755

4756

(3003181) Sodium [Moles/volume] in Urine

161

546

3.00

35.94

1.3

1.2

64.78

66.86

mmol/l

0.27

137

411

(3006184) Hemoglobin [Mass/volume] in Capillary blood

277

1239

2.29

35.21

2.1

2.2

125.77

129.06

g/l

1.23

216

888

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

392

2008

2.01

35.16

2.9

2.7

0.35

u/ml

0.11

236

1110

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

472

2608

1.87

33.79

4.8

3.6

50.93

47.35

2.23

463

2572

(3015377) Calcium [Moles/volume] in Serum or Plasma

2423

19468

1.38

32.70

3.1

3.4

2.35

mmol/l

1.70

2055

16725

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

215

889

2.46

32.64

2.2

1.5

0.95

0.80

nmol/l

1.63

175

742

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

998

6803

1.55

32.38

3.6

4.3

243.83

248.03

u/l

0.35

943

6400

(3029937) Albumin [Presence] in Urine by Test strip

1961

15266

1.40

31.86

5.1

4.1

0.00

estimate

1.94

488

4818

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

505

2913

1.79

31.40

8.4

8.1

24.20

24.36

mmol/l

0.49

485

2796

(3033658) Prothrombin time (PT) actual/Normal

1750

13397

1.41

31.23

4.6

3.8

85.52

85.37

0.08

1700

13073

(3018405) Lactate [Moles/volume] in Arterial blood

405

2185

1.91

31.18

4.6

3.8

1.41

1.36

mmol/l

0.46

397

2164

(3007164) IgA [Mass/volume] in Serum or Plasma

1175

8360

1.49

31.00

1.6

1.4

2.65

2.64

g/l

0.08

723

4739

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1228

8844

1.47

30.41

3.9

3.0

2.56

2.12

e6/l

0.99

801

4970

(3004809) Band form neutrophils/100 leukocytes in Blood

224

983

2.32

29.79

3.4

3.6

1.77

1.58

0.27

206

858

(3019060) Gas panel - Arterial blood

647

4057

1.66

29.68

5.5

4.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

702

4499

1.62

29.52

1.9

1.7

1.65

1.53

2.58

583

3804

(3020876) Protein [Mass/time] in 24 hour Urine

154

569

2.75

29.43

2.2

2.3

1.18

1.14

g/24h

0.06

256

(3005719) IgG [Mass/volume] in Serum or Plasma

578

3539

1.69

29.02

3.0

2.8

10.39

10.69

g/l

0.70

539

3214

(3030467) Casts [#/volume] in Urine by Automated count

2030

16102

1.37

28.80

4.2

3.1

0.41

0.48

e6/l

0.72

1669

12441

(3045414) Leukocytes [Presence] in Urine

426

2399

1.83

28.64

2.4

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

175

700

2.54

28.54

1.4

—

(3026782) Osmolality of Urine

1517

11479

1.41

28.53

3.7

2.8

534.66

558.15

mosm/kgh2o

4.15

1329

9743

(3000034) Microalbumin [Mass/volume] in Urine

138

491

2.85

28.32

3.8

2.7

61.29

27.44

mg/l

1.19

109

346

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

925

6385

1.52

28.02

1.9

1.7

—

(3000330) Specific gravity of Urine by Test strip

498

2956

1.74

27.98

3.7

3.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

174

701

2.52

27.96

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

224

1011

2.26

27.90

2.9

2.4

32.42

35.01

umol/l

0.94

199

891

(3005988) Vibrio sp identified in Specimen by Organism specific culture

174

702

2.52

27.88

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

178

726

2.49

27.87

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

173

700

2.51

27.55

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

173

712

2.47

26.59

1.4

—

(3022145) Colonoscopy Study observation

869

5995

1.51

26.29

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

209

3.81

26.20

1.2

1.3

1.56

1.54

g/l

0.12

209

(3028026) IgM [Mass/volume] in Serum or Plasma

460

2720

1.74

26.17

1.8

1.9

1.23

1.47

g/l

1.01

416

2431

(3004119) Hemoglobin [Mass/volume] in Venous blood

534

3335

1.65

24.76

3.7

3.0

125.24

127.98

g/l

1.91

523

3247

(3008757) Leukocyte morphology finding [Identifier] in Blood

160

657

2.47

24.73

3.6

4.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

635

4140

1.59

24.70

1.9

1.5

—

(36304419) Bacteria [Presence] in Urine

1930

15514

1.34

24.21

4.1

3.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

236

1158

2.07

23.83

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

278

1450

1.96

23.67

3.5

2.5

—

(40761535) Cells panel - Urine sediment

772

5320

1.51

23.33

4.2

3.4

—

(3037756) Immunofixation for Serum or Plasma

248

1250

2.02

23.28

1.4

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

327

1814

1.84

23.06

3.3

3.1

2.23

2.86

ratio

0.26

118

(3017732) Neutrophils [#/volume] in Blood

560

3602

1.60

23.02

4.0

3.0

5.42

5.32

e9/l

0.04

394

2728

(40768804) Tissue Pathology biopsy report

2604

21948

1.30

22.92

2.4

2.2

—

(3037522) Nuclear Ab [Titer] in Serum

840

5912

1.48

22.85

1.4

1.3

515.88

517.87

titre

0.01

194

1272

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

894

6376

1.46

22.72

2.0

1.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

322

3.04

22.61

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

685

4663

1.52

21.88

4.3

3.9

0.69

0.98

4.23

321

1647

(3034860) Kappa light chains.free [Mass/volume] in Serum

332

1882

1.80

21.82

3.3

3.1

54.85

57.12

mg/l

0.14

294

1508

(3034770) Mitochondria Ab [Titer] in Serum

227

1138

2.03

21.65

1.2

840.00

941.75

titre

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

179

820

2.21

21.58

2.0

2.1

26.65

27.77

mg/l

0.09

207

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

331

1881

1.80

21.58

3.3

3.1

38.12

46.96

mg/l

1.05

294

1510

(3044927) Protein electrophoresis panel - Urine

146

615

2.40

21.40

1.2

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

651

4414

1.52

21.16

4.3

3.9

0.06

0.10

1.16

292

1413

(3007566) Smooth muscle Ab [Titer] in Serum

226

1142

2.01

21.09

1.2

198.95

151.00

titre

0.27

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

675

4617

1.51

21.05

4.1

2.5

57.31

63.28

ml/min/173m2

4.06

320

1810

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

268

3.16

20.97

4.9

2.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

381

2275

1.71

20.90

1.3

1.5

16.37

20.24

u/ml

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

169

770

2.22

20.66

6.1

6.5

12.32

11.71

mg/l

0.89

153

701

(3014271) Vancomycin [Susceptibility]

348

2.84

20.30

3.2

2.9

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

236

3.25

19.86

1.3

1.2

1.11

1.20

nmol/l

0.24

184

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1245

9617

1.36

19.72

1.3

1.2

1.40

1.88

u/ml

0.93

349

2408

(40760888) Immunoglobulin light chains.free panel - Serum

260

1412

1.87

19.64

3.5

3.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1258

9739

1.36

19.63

3.5

2.8

1.22

1.43

e6/l

0.27

828

5815

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

898

6585

1.42

19.44

3.4

4.1

12.10

25.72

ug/l

2.19

773

5471

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

392

2408

1.67

19.34

4.7

3.6

23.92

24.16

mmol/l

0.72

387

2351

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

310

1786

1.77

19.31

1.4

1.6

210.63

269.30

titre

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

273

3.03

19.08

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

273

3.03

19.08

1.3

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

665

4626

1.48

19.03

1.9

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

263

1451

1.84

18.91

1.4

1.5

25.68

19.27

iu/ml

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

102

388

2.65

18.56

1.1

1.2

—

u/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

283

2.96

18.54

1.4

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

283

2.96

18.54

1.4

2.1

—

(3018418) pH of Serum or Plasma

2009

16742

1.28

18.23

5.2

3.5

7.40

0.68

319

3225

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

363

2221

1.67

18.19

2.7

—

(3003338) MCHC [Mass/volume]

4660

42847

1.27

18.17

29.9

19.7

330.85

332.06

g/l

15.61

4628

42415

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2915

25432

1.25

17.89

5.1

5.4

3.28

3.90

ug/l

0.45

2618

22603

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

255

1429

1.81

17.45

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

133

3.86

17.37

1.6

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

365

2266

1.64

17.29

2.3

2.2

7.69

7.40

g/l

2.52

320

1979

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

364

2263

1.64

17.14

2.3

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

363

2262

1.64

16.94

2.3

2.2

3.70

3.73

g/l

0.12

319

1978

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

279

2.85

16.60

2.5

2.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

479

3211

1.53

16.34

2.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

361

2.60

16.31

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

131

3.76

16.14

2.2

1.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

317

2.70

16.14

2.3

1.8

3.14

2.26

u/field

0.23

202

(3027456) Digoxin [Moles/volume] in Serum or Plasma

251

1437

1.77

16.02

3.1

0.87

0.81

nmol/l

0.83

189

1111

(3016750) Collection duration of Urine

325

2.67

15.92

1.9

2.1

487.35

489.62

min

0.08

231

(3036489) Thrombin time

283

1681

1.71

15.86

2.0

21.49

21.77

0.25

244

1483

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

366

2327

1.60

15.75

5.3

4.9

1.56

1.63

0.84

358

2154

(3025159) Blasts/100 leukocytes in Blood

589

4153

1.46

15.66

4.3

4.0

0.40

0.27

0.13

232

1179

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

371

2.53

15.44

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

965

7420

1.35

15.42

1.3

1.2

12.91

14.63

u/ml

0.13

352

2660

(40768446) Kidney Pathology biopsy report

137

3.60

15.14

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

267

1583

1.71

15.08

1.4

245.42

268.34

ug/g

1.07

153

958

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

111

487

2.30

14.96

1.4

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

111

487

2.30

14.96

1.4

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

111

487

2.30

14.96

1.4

1.8

—

(3025941) Bacteria identified in Stool by Culture

392

2568

1.56

14.85

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

311

1928

1.64

14.84

1.6

1.7

36.74

38.74

u/l

0.93

254

1648

(3047181) Lactate [Moles/volume] in Blood

284

1723

1.68

14.73

6.1

5.8

1.44

1.32

mmol/l

1.09

264

1508

(3048689) Calprotectin [Mass/mass] in Stool

699

5156

1.40

14.44

2.0

2.1

201.75

153.44

ug/g

0.72

531

3953

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

440

2976

1.51

14.39

10.4

9.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

121

562

2.17

14.24

4.5

2.7

—

(3011985) Renin [Units/volume] in Plasma

112

506

2.23

14.11

1.4

1.3

128.31

48.71

mu/l

1.85

100

451

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

331

2112

1.60

14.05

2.5

2.2

2.87

2.99

g/l

1.16

287

1828

(46235355) HIV 1 and 2 tests - Meaningful Use set

719

5353

1.38

14.03

1.9

1.5

—

(3042733) HLA Ab [Presence] in Serum

4.00

14.03

6.3

4.6

—

(40758558) Short blood count panel - Blood

1603

13372

1.26

13.69

6.9

6.6

—

(3000494) Fungus identified in Specimen by Culture

814

6206

1.35

13.66

1.6

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

996

7849

1.31

13.30

1.3

38.65

39.61

iu/ml

0.06

289

2410

(3002079) Sodium [Moles/time] in 24 hour Urine

140

3.37

13.24

1.1

1.3

164.79

159.51

mmol/24h

0.14

140

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

329

2128

1.57

13.20

2.3

2.2

9.69

10.36

g/l

1.77

283

1829

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

386

2588

1.52

13.17

3.0

2.4

0.66

0.65

0.18

386

2575

(3004775) Volume in Urine collected for unspecified duration

103

467

2.22

12.91

2.4

2.1

659.68

644.06

0.10

294

(3020191) Ethanol [Moles/volume] in Serum or Plasma

290

2.57

12.82

1.7

1.2

1.47

1.32

promille

0.35

220

(3007930) Methemoglobin/Hemoglobin.total in Blood

348

2300

1.54

12.69

5.4

5.0

0.85

0.88

0.60

342

2128

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

157

843

1.88

12.42

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

157

843

1.88

12.42

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

4785

44830

1.22

12.42

26.4

17.3

16.15

15.40

10.39

4739

43808

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

228

1371

1.69

12.29

2.4

3.73

3.58

g/l

0.67

217

1305

(1616796) Gas panel - Central venous blood

205

1198

1.73

12.26

3.5

3.6

—

(3045424) Erythrocytes [Presence] in Urine

164

899

1.84

12.17

1.6

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

236

1443

1.66

11.95

1.5

1.6

13648.94

15401.60

e6/l

0.17

168

1048

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

110

530

2.09

11.86

2.4

2.1

2.19

1.81

u/field

0.35

169

(3051593) INR in Capillary blood by Coagulation assay

334

2.38

11.68

11.2

13.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

337

2.36

11.46

1.2

2.15

2.14

mmol/l

0.02

320

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

259

1640

1.60

11.41

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

620

4660

1.36

11.35

3.1

2.4

37.45

64.59

u/l

0.85

515

3990

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

126

649

1.96

11.32

1.1

7.37

83.54

iu/ml

2.88

138

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

108

527

2.07

11.28

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

372

2558

1.48

11.25

1.2

1.3

195.55

259.05

u/ml

1.02

346

2334

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

217

1320

1.66

11.23

1.8

1.5

1.22

1.16

g/l

1.98

205

1249

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

354

2412

1.49

11.21

3.2

3.0

4.33

4.38

pmol/l

0.48

305

2093

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

211

1276

1.67

11.17

1.9

1.5

0.25

0.23

g/l

2.96

200

1208

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

137

731

1.89

11.10

3.5

2.5

374.59

1956.79

u/ml

1.20

(3022689) Creatine [Moles/volume] in Urine

122

3.29

10.91

1.5

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

123

638

1.94

10.85

3.0

3.7

60.50

56.82

1.15

107

525

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

101

489

2.08

10.79

1.3

287.65

286.21

pmol/l

0.01

418

(3044889) 12 lead EKG panel

4205

39154

1.19

10.67

4.9

4.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

263

2.49

10.61

1.2

1.1

53.39

25.46

u/l

1.02

235

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

263

2.49

10.61

1.2

1.1

124.63

85.30

u/l

1.08

236

(3020491) Glucose [Moles/volume] in Blood

371

2.22

10.41

1.6

2.1

7.57

6.91

mmol/l

1.02

247

(1761482) Bacteria [#/volume] in Urine by Culture

251

1626

1.56

10.07

4.0

4.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

184

1104

1.68

10.07

1.5

1.6

—

(3016038) Potassium [Moles/volume] in Urine

188

2.73

10.05

1.1

33.27

37.07

mmol/l

0.58

148

(3006442) Creatine [Moles/volume] in Serum or Plasma

332

2.27

10.05

2.2

1.5

100.55

86.71

umol/l

1.14

332

(3038026) Centromere Ab [Units/volume] in Serum

436

2.10

10.03

1.2

30.21

68.53

u/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

140

779

1.81

9.98

1.2

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

404

2.14

9.97

1.2

2.40

3.73

u/ml

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

199

1224

1.64

9.91

1.3

1.2

7.58

38.19

u/ml

—

(3008295) Osmolality of Serum or Plasma

379

2.18

9.90

1.2

1.3

279.95

285.31

mosm/kgh2o

1.19

274

(3052851) Hemolysis interference index of Serum or Plasma

250

1628

1.56

9.82

3.5

3.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

105

535

1.98

9.80

1.4

1.3

—

nmol/l

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

427

2.10

9.78

1.2

43.63

38.94

u/ml

—

(3002179) Metamyelocytes/100 leukocytes in Blood

562

4264

1.35

9.67

4.2

3.8

0.60

0.72

0.80

253

1421

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

282

2.35

9.61

1.0

292.22

282.73

mg/l

0.49

245

(3024928) Oxygen saturation in Venous blood

170

1014

1.69

9.54

3.3

2.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

118

633

1.88

9.47

4.9

4.3

358.10

351.52

umol/l

0.21

526

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

100

510

1.97

9.33

1.2

63.91

67.03

u/l

0.17

446

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

231

2.48

9.32

1.5

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

231

2.48

9.32

1.5

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

115

616

1.88

9.28

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

281

1909

1.49

9.08

2.7

2.3

1.01

1.18

g/l

0.30

236

1586

(3010838) Calcium [Moles/time] in 24 hour Urine

126

700

1.81

9.07

1.5

1.7

4.43

4.88

mmol/24h

0.77

106

594

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.45

9.05

6.5

1.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

108

572

1.90

9.03

1.7

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

434

3199

1.38

8.99

8.2

6.4

24.73

24.90

mmol/l

0.45

429

3164

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

194

2.59

8.96

3.7

2.2

—

(1761868) Lipid panel - Serum or Plasma

1781

15576

1.19

8.95

4.2

3.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

185

1148

1.63

8.94

1.3

1.2

2.32

6.17

u/ml

0.71

113

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

149

2.83

8.93

1.6

2.0

57.88

140.01

umol/l

1.76

(3002256) Pathology report gross observation

909

7431

1.26

8.89

1.4

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

104

547

1.92

8.89

1.4

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

186

1159

1.62

8.84

1.3

1.2

9.27

4.93

u/ml

0.28

183

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

113

612

1.86

8.83

1.1

1.58

1.52

g/l

0.70

103

544

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

332

2.18

8.80

1.1

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

111

600

1.86

8.74

1.4

1.3

0.64

1.36

nmol/l

0.52

106

576

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

233

2.41

8.68

1.5

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

101

533

1.91

8.56

1.5

1.4

—

(3024471) HLA-A [Type]

115

3.05

8.52

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

577

1.87

8.50

1.5

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

182

1140

1.61

8.49

1.3

734.26

576.04

mg/l

0.71

173

1081

(44816559) Phosphatidylethanol [Mass/volume] in Blood

122

687

1.79

8.43

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

425

2.01

8.42

1.4

—

(3023419) Bacteria identified in Sputum by Culture

156

942

1.67

8.41

2.7

2.4

—

(3024932) HLA-DR beta [Type]

111

3.07

8.37

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

497

1.92

8.28

1.3

1.2

303.32

336.88

nmol/l

0.80

395

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

158

967

1.65

8.10

7.8

4.5

643.47

2101.35

iu/ml

0.45

142

(3024980) IgG subclass 4 [Mass/volume] in Serum

125

718

1.75

8.09

1.8

1.6

0.65

0.85

g/l

1.61

101

533

(3020911) Cortisol [Moles/time] in 24 hour Urine

103

3.12

8.08

1.4

1.3

80.43

199.78

nmol/24h

0.83

103

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

447

1.96

8.01

1.3

1.2

1.55

1.40

nmol/l

0.70

396

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

109

603

1.82

8.01

1.4

1.3

0.14

0.34

nmol/l

1.39

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

127

737

1.74

7.94

1.4

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

149

905

1.66

7.88

1.7

1.4

31.30

32.59

g/l

0.62

141

804

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

110

3.01

7.86

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

204

1342

1.54

7.74

2.1

2.2

89.09

88.63

0.10

195

1295

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

136

813

1.69

7.65

1.8

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

135

807

1.69

7.60

3.9

2.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

255

1764

1.46

7.59

2.4

2.1

37.17

37.40

g/l

0.22

209

1472

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

109

615

1.78

7.53

1.4

1.3

293.62

523.98

u/l

1.13

103

578

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

451

1.92

7.48

1.9

1.5

—

1445.33

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

192

1256

1.54

7.48

3.5

3.2

1.81

1.59

mg/l

2.81

171

1123

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

544

1.83

7.46

1.5

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1480

12912

1.19

7.45

4.7

3.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

119

692

1.73

7.42

1.7

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

196

2905

0.67

7.29

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

109

1847

0.58

7.28

1.4

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

189

1241

1.54

7.26

1.6

1.8

12.00

11.60

mg/l

0.22

174

1141

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

237

1638

1.46

7.11

2.5

2.2

0.06

0.04

g/l

0.13

216

1463

(3009214) Lutropin [Units/volume] in Serum or Plasma

144

893

1.63

7.07

1.4

10.10

9.91

u/l

0.05

119

723

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

199

1330

1.51

7.05

1.5

1.6

—

(3042631) Mycobacterium sp identified in Specimen

146

910

1.62

7.02

2.5

2.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

115

674

1.72

6.99

1.5

1.2

269.35

282.48

u/ml

0.18

404

(40761536) Microorganisms panel - Urine sediment

366

4837

0.74

6.99

5.2

3.9

—

(3017704) Immunofixation for Urine

298

2.09

6.91

1.3

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

156

1001

1.57

6.67

1.4

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

152

970

1.58

6.65

1.3

1.2

1.89

5.50

u/ml

0.94

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

240

1688

1.44

6.59

2.0

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.96

6.52

1.8

1.3

188.40

122.00

ng/l

0.61

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

220

2.24

6.49

1.4

1.3

—

(3035880) pH of Pleural fluid

347

1.97

6.46

1.4

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

203

1389

1.48

6.45

1.2

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

136

852

1.61

6.44

2.8

2.5

66.42

63.37

0.87

136

847

(3028433) Virus identified in Specimen by Culture

190

2.32

6.38

1.1

—

(3001729) Color of Synovial fluid

3.73

6.35

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

364

1.93

6.31

1.3

1.1

—

(3051651) Icteric interference index of Serum or Plasma

305

2.01

6.16

3.5

2.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

468

1.80

6.13

1.5

1.4

6.57

7.09

g/l

0.54

321

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

146

945

1.56

6.05

1.6

1.5

5.22

4.13

iu/l

0.33

284

(3021879) Hepatitis B virus core Ab [Presence] in Serum

352

2677

1.33

6.04

1.4

1.3

—

(4062490) Immunoglobulin typing, IgG

463

1.80

6.04

1.6

1.4

—

(3017509) Phencyclidine [Presence] in Urine

6.68

6.02

2.0

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

165

2.37

5.94

2.0

2.1

64.71

55.32

umol/l

0.84

134

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

122

762

1.61

5.89

1.3

1.5

59.96

60.73

0.07

489

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

179

1218

1.48

5.88

2.4

2.5

211.63

200.25

0.83

166

1156

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

154

2.41

5.85

24.0

17.6

1255.35

1316.95

nmol/l

0.19

147

(3024139) IgG subclass 3 [Mass/volume] in Serum

468

1.78

5.84

1.6

1.4

0.39

0.45

g/l

0.84

321

(3028192) IgG subclass 2 [Mass/volume] in Serum

468

1.78

5.84

1.6

1.4

2.48

2.94

g/l

1.93

322

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

319

1.95

5.80

1.4

30.07

29.07

u/l

0.07

268

(3014148) Varicella zoster virus Ab [Titer] in Serum

355

1.90

5.75

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

192

1334

1.45

5.69

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

228

2.11

5.59

1.3

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

128

822

1.57

5.53

1.6

1.5

1507.03

2218.49

e6/l

1.16

109

600

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.73

5.51

1.1

1.2

0.82

0.68

umol/24h

0.57

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

199

1404

1.43

5.45

1.9

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

417

3295

1.28

5.43

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

198

1399

1.43

5.38

2.8

3.3

1685.93

854.07

u/ml

0.29

176

1276

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2228

20440

1.13

5.37

4.6

22.75

21.88

1.80

1109

11025

(3034274) Bile acid [Moles/volume] in Serum --fasting

266

2.00

5.35

1.4

1.8

12.19

10.31

umol/l

0.15

193

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

286

2151

1.34

5.33

2.7

3.5

624.69

1471.88

u/ml

0.79

254

1841

(3010503) CD19 cells [#/volume] in Blood

322

1.90

5.32

2.5

2.2

0.40

0.12

e9/l

0.59

311

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

315

1.91

5.32

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

604

1.65

5.29

1.4

1.3

63373.57

159514.28

e6/l

1.54

414

(3028707) Methadone [Presence] in Urine by Screen method

282

1.96

5.23

2.7

2.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

126

818

1.55

5.21

1.7

1.4

25.30

17.53

u/ml

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

3.13

5.18

1.1

—

6.99

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

340

1.86

5.15

2.2

2.4

—

(3011648) Oxygen content in Venous blood

340

1.86

5.15

2.6

2.4

11.47

10.73

0.71

340

(3041354) Potassium [Moles/volume] in Venous blood

119

766

1.56

5.12

2.3

4.14

4.08

mmol/l

0.80

119

758

(21494755) Public health laboratory ask at order entry panel

176

2473

0.70

5.02

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

400

3178

1.27

5.01

2.5

19.75

23.70

au/ml

0.22

186

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

174

1218

1.44

5.00

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

174

1218

1.44

5.00

1.4

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

514

1.68

4.99

1.2

8.11

7.75

mmol/l

0.40

435

(3035285) Chloride [Moles/volume] in Venous blood

118

766

1.55

4.91

2.3

105.83

105.88

mmol/l

0.04

118

758

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.12

4.90

4.7

2.2

0.84

0.33

u/field

1.00

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

144

976

1.49

4.90

1.3

1.4

29.07

18.73

e6/l

0.36

118

774

(3044941) Cell count panel - Synovial fluid

131

871

1.51

4.88

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

332

1.84

4.88

1.1

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

144

977

1.48

4.87

1.4

1189.86

989.76

e6/l

0.09

126

811

(3020891) Body temperature

326

2533

1.30

4.87

6.6

4.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

109

699

1.57

4.79

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.07

4.78

1.1

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

306

1.87

4.77

2.4

2.2

236.44

78.34

ug/min

0.61

(3026389) Candida sp identified in Specimen by Organism specific culture

111

716

1.56

4.76

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.16

4.75

4.7

4.5

—

(3024869) Neuronal Ab [Presence] in Serum

114

2.46

4.70

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

410

1.74

4.69

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

382

1.76

4.63

2.3

2.2

39.94

37.83

0.46

376

(4200892) Spirometry reversibility

495

4071

1.23

4.61

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

115

754

1.53

4.60

2.4

2.3

—

(3024263) Appearance of Synovial fluid

310

1.85

4.60

1.4

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

118

779

1.52

4.58

1.8

1.6

299.17

293.87

mu/l

0.06

113

717

(3028308) Erythrocytes [#/volume] in Pleural fluid

116

763

1.53

4.57

1.6

1.5

107050.53

56817.67

e6/l

0.46

456

(3051611) Lipemic interference index of Serum or Plasma

582

1.61

4.55

3.4

2.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

187

2.09

4.50

35.3

25.9

119.57

114.33

ug/l

0.13

163

(3019832) Treponema pallidum Ab [Presence] in Serum

247

1870

1.33

4.47

1.7

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.59

4.46

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

439

1.69

4.46

1.3

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

493

1.65

4.43

1.5

1.7

22.67

27.50

u/ml

0.24

105

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

218

1622

1.36

4.43

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

129

877

1.48

4.37

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

136

935

1.46

4.35

1.2

1.4

35.85

40.77

u/l

0.23

121

809

(3030313) Adrenal Ab [Titer] in Serum

7.51

4.35

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

231

1.95

4.33

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

232

1.95

4.28

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

247

1.91

4.23

1.3

1.5

12.12

6.21

u/l

0.60

203

(3048879) Bone marrow aspiration report

199

2.02

4.21

1.3

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

134

2.24

4.14

1.3

1.1

1557.59

1558.20

miu/ml

0.00

134

(4035726) Immunohistochemistry procedure

601

5098

1.20

4.10

1.4

—

(36660697) Celiac disease serology panel - Serum

420

3439

1.24

4.10

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

122

2.30

4.09

1.4

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

555

1.57

3.98

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

348

1.73

3.96

1.0

—

(3004451) EKG impression Narrative

253

1.86

3.96

1.5

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

312

1.77

3.92

1.4

1.6

9.11

6.08

u/l

0.56

251

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

327

1.75

3.91

3.5

3.9

—

(3003694) ABO and Rh group [Type] in Blood

1512

13773

1.13

3.91

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

320

1.76

3.90

1.6

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.89

3.89

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

373

1.70

3.87

1.2

1.1

—

(40768441) Liver Pathology biopsy report

358

1.71

3.87

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

717

6207

1.17

3.87

3.9

3.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

262

2045

1.29

3.85

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

263

1.83

3.84

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

204

1539

1.34

3.83

2.5

2.2

0.00

g/l

0.76

184

1367

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

12.01

3.76

8.5

5.6

1.77

2.35

g/l

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

430

1.63

3.76

1.4

1.3

440.00

338.54

titre

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

102

2.36

3.73

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

195

1.95

3.71

1.3

190.30

485.70

ug/l

0.56

109

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

419

1.63

3.62

1.4

1.3

45.56

76.86

titre

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

156

2.06

3.60

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

123

2.20

3.59

1.5

1.4

0.43

0.41

ug/l

0.06

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

4.77

3.55

1.7

1.2

0.60

1.00

u/field

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

263

1.79

3.54

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

271

1.78

3.52

1.0

1.1

4.47

12.15

nmol/l

0.77

(3017569) Oxygen content in Arterial blood

279

1.76

3.49

1.9

2.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

228

1.85

3.49

1.1

1.10

1.07

ratio

—

(3000764) Benzodiazepines [Presence] in Urine

622

1.50

3.49

2.1

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

207

1.89

3.47

1.5

1.8

6603.00

14902.07

u/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

317

1.71

3.46

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

198

1512

1.32

3.46

2.5

2.2

0.00

g/l

-0.00

183

1363

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

119

2.19

3.43

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

119

2.19

3.43

1.4

1.3

—

(3016879) Cocaine [Presence] in Urine

585

1.51

3.41

2.1

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

105

725

1.46

3.38

1.8

1.4

115.05

126.97

u/ml

0.45

169

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

188

1.92

3.37

2.9

2.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

453

1.57

3.31

1.2

1.1

—

3.54

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.03

3.24

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

156

1.99

3.23

1.9

2.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

576

1.50

3.23

1.5

31.12

28.95

0.20

363

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

129

2.10

3.23

1.1

—

(3021788) Differential panel - Synovial fluid

146

1078

1.36

3.22

1.3

1.5

—

(3036180) Methadone [Presence] in Urine

2.38

3.22

2.3

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

118

841

1.41

3.21

1.1

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.44

3.21

1.3

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1504

13840

1.11

3.19

1.7

1.6

1.59

1.30

mmol/l

14.84

1292

11155

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

123

2.12

3.19

1.7

1.3

12.87

16.45

pmol/l

2.80

100

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

164

1.96

3.18

2.8

2.7

31.16

27.77

umol/l

1.11

131

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

130

2.08

3.17

2.5

2.3

—

(3027008) Opiates [Presence] in Urine

629

1.47

3.14

2.1

1.7

—

(3014891) Appearance of Pleural fluid

2.41

3.13

1.3

1.2

—

(40768806) Pleura Pathology biopsy report

102

712

1.44

3.13

1.7

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.54

3.12

2.1

2.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

915

8198

1.13

3.08

9.6

7.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

268

1.72

3.07

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

147

1096

1.35

3.07

1.0

1.1

16.40

9.41

u/ml

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

132

2.05

3.06

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

115

825

1.40

3.04

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

617

1.46

3.04

2.1

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

154

1158

1.34

3.04

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

254

1.74

3.03

1.4

2.2

15.70

17.18

nmol/l

0.52

240

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.50

3.03

2.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

278

1.70

2.98

1.3

1.2

215.95

446.05

u/l

1.12

261

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

306

2517

1.23

2.95

1.1

1.2

114.93

120.28

iu/ml

0.10

122

871

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

325

1.64

2.94

1.7

2.5

486.69

499.54

e6/l

0.05

275

(3023487) Leukocytes [#/volume] in Peritoneal fluid

198

1.82

2.92

1.9

2.1

1113.00

3080.66

e6/l

0.37

140

(3028300) Cannabinoids [Presence] in Urine

632

1.45

2.89

2.1

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

2.86

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

297

1.65

2.85

4.9

3.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

256

2076

1.24

2.84

3.8

3.9

112.62

88.60

u/ml

0.18

250

1994

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

172

1329

1.30

2.83

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

186

1.83

2.82

10.5

5.5

69.75

71.48

0.14

147

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.23

2.79

1.2

1.5

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.34

2.75

9.0

5.5

346.60

437.50

umol/l

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

176

1371

1.29

2.74

1.7

1.6

20.87

6.59

iu/ml

0.30

310

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.36

2.72

1.1

18.18

18.94

u/l

0.08

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.71

1.5

2.4

62.57

57.39

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

6.00

2.69

1.8

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

3.45

2.68

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

156

1200

1.31

2.67

1.8

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.18

2.66

1.8

1.6

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.33

2.64

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

162

1.86

2.61

1.0

1.1

100.86

93.38

1.03

122

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.67

2.59

1.7

1.5

18.80

16.49

nmol/l

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

698

1.40

2.58

1.2

204.41

220.76

miu/ml

0.14

244

(21494814) CD8 cells/100 lymphocytes in Specimen

207

1.74

2.56

2.7

1.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

341

2881

1.19

2.54

1.3

44.25

62.89

au/ml

0.73

167

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.73

2.54

1.2

2.19

1.85

umol/24h

0.25

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

517

1.46

2.52

1.1

0.68

2.24

u/ml

2.63

281

(3021589) Normoblasts [#/volume] in Blood

2473

23498

1.08

2.52

12.1

9.5

0.00

e9/l

0.29

2087

19279

(40768443) Skin Pathology biopsy report

311

2611

1.20

2.49

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1137

0.71

2.48

1.5

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.38

2.47

1.0

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

134

1022

1.32

2.47

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

210

1.72

2.45

1.2

42.04

40.16

g/l

0.38

116

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

173

1.80

2.45

3.1

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.55

2.44

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.55

2.44

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

174

1.79

2.41

1.8

18327.00

19368.69

e6/l

0.03

102

(4281824) Cell count and differential, peritoneal fluid

500

1.44

2.36

1.3

1.2

—

(3016228) CD19 cells/100 cells in Blood

213

1.69

2.35

2.8

1.8

11.11

7.79

0.53

207

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

165

1304

1.27

2.34

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

138

1067

1.30

2.32

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

252

1.63

2.32

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

110

824

1.34

2.31

1.3

1.2

47.70

41.40

u/ml

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.18

2.30

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.18

2.30

1.1

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

168

1334

1.27

2.30

1.7

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.38

2.29

1.1

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

479

1.44

2.27

2.1

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

185

1.73

2.27

1.1

1.10

1.12

u/l

0.05

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

597

1.40

2.25

3.6

3.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

127

1.89

2.25

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

682

1.37

2.25

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

135

1046

1.30

2.25

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

1.98

2.25

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.28

2.24

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.28

2.24

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

342

1.52

2.23

2.6

2.0

—

(3033799) Differential panel - Peritoneal fluid

172

1.75

2.20

1.9

—

(3011544) Albumin [Mass/volume] in Pleural fluid

2.41

2.19

1.2

1.1

18.60

18.74

g/l

0.02

(40767503) Oxygen content in Capillary blood by calculation

151

1193

1.27

2.17

2.9

2.3

15.75

16.15

0.62

103

572

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.10

2.12

2.9

2.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

183

1.70

2.07

1.1

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

431

1.44

2.06

1.0

1.1

0.93

1.26

u/ml

0.16

201

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

238

1.60

2.03

1.4

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

575

1.38

2.03

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

232

1.60

1.98

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

441

4988

0.88

1.97

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

201

1661

1.22

1.97

1.2

0.70

1.07

u/ml

0.44

154

(3014765) Yersinia sp identified in Stool by Organism specific culture

173

1408

1.23

1.96

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

141

1.78

1.96

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

171

1.70

1.96

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

1.94

1.1

1.3

99.94

53.26

mu/l

0.32

(3026726) Creatinine [Moles/volume] in Specimen

2.45

1.92

3.2

1.9

556.27

596.57

umol/l

0.03

(42529406) Shigella sp [Presence] in Stool by Culture

173

1413

1.23

1.91

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.18

1.88

1.3

1.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.18

1.88

2.3

1.4

4.40

4.68

nmol/l

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.03

1.85

1.1

1.2

43.33

53.70

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

144

1.74

1.84

1.1

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.53

1.83

4.0

2.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

130

1.77

1.81

1.2

1.1

—

(3008898) HLA-B27 [Presence]

137

1098

1.25

1.81

1.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

327

1.47

1.80

1.8

2.0

89.00

45.65

umol/l

—

(3007916) DNA double strand Ab [Titer] in Serum

2.27

1.80

1.1

1.2

—

54.38

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.57

1.80

1.1

—

mmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

712

1.31

1.76

1.3

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

296

1.49

1.76

2.1

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

216

1.58

1.75

3.4

3.3

79.40

74.81

mg/l

0.10

144

(3038071) Oxygen [Partial pressure] in Mixed venous blood

102

1.87

1.75

8.2

7.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.50

1.73

1.1

18.22

10.81

u/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

224

1897

1.19

1.73

1.2

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

249

1.53

1.72

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

249

1.53

1.72

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

542

1.35

1.71

1.2

1.1

125.92

113.48

2.39

484

(3023410) Appearance of Cerebral spinal fluid

390

1.41

1.69

1.4

1.5

—

(3011288) Drugs identified in Urine by Screen method

407

1.40

1.69

2.6

2.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

133

1.73

1.69

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

133

1.73

1.69

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

133

1.73

1.69

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

133

1.73

1.69

1.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

284

1.48

1.66

1.1

1.2

98.30

90.54

u/l

0.22

235

(3012441) Differential panel - Pleural fluid

693

1.30

1.66

1.7

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

119

1.77

1.65

1.8

1.2

136.40

43.19

mg/l

0.28

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.10

1.65

1.2

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.03

1.64

1.4

1.1

6.89

7.47

mg/l

0.13

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.44

1.64

1.3

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

142

1.69

1.64

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

127

1.73

1.63

8.0

7.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

169

1403

1.21

1.63

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

564

1.33

1.63

1.7

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

564

1.33

1.63

1.7

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

3.00

1.58

1.0

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.69

1.58

1.3

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.69

1.58

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

447

1.37

1.57

1.0

1.1

3.92

4.52

u/ml

0.14

229

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.85

1.55

1.4

3.4

—

(40768800) Prostate Pathology biopsy report

145

1754

0.82

1.55

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

256

1.49

1.54

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

217

1854

1.18

1.54

1.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.97

1.53

1.1

1.2

7.45

6.88

mmol/l

—

(3009871) Measles virus Ab [Titer] in Serum

115

1.74

1.52

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

124

1007

1.24

1.51

1.6

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

123

998

1.24

1.51

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

104

828

1.26

1.50

1.7

1.5

244.14

208.99

pmol/l

0.25

806

(40758358) Immune stain study

2.86

1.50

1.0

—

(21494434) Karyotype in Bone marrow

538

1.32

1.49

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

259

1.47

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.37

1.45

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.73

1.43

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.73

1.43

1.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.82

1.41

1.9

1.4

5.57

10.49

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.18

1.39

1.0

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

820

1.25

1.38

1.5

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.14

1.33

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

638

1.27

1.31

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

125

1035

1.21

1.30

1.4

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

129

1.63

1.29

1.5

1.6

10.18

9.13

ug/l

0.39

129

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.35

1.29

1.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1188

11252

1.07

1.27

2.9

3.2

2.46

mmol/l

0.72

994

9874

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.82

1.25

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.40

1.24

1.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.22

1.24

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.00

1.23

1.0

1.5

—

(40757373) Influenza virus identified in Isolate

100

1.70

1.23

1.9

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.63

1.21

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

143

0.49

1.20

1.4

1.5

—

(3000492) Spirometry study

490

4501

1.10

1.16

1.6

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.00

1.16

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

248

1.41

1.16

1.3

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

547

5052

1.09

1.15

1.6

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

215

1.44

1.15

1.4

1.3

—

(3045788) Cell count panel - Pleural fluid

624

1.25

1.15

1.6

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

207

1.45

1.14

1.1

65.47

723.86

ng/l

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

356

0.67

1.14

1.3

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

653

1.24

1.12

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.96

1.11

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.96

1.11

1.4

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

547

1.26

1.10

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

450

1.29

1.10

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

194

0.57

1.08

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

128

1.56

1.08

2.6

13.17

7.23

mmol/l

1.30

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

461

1.28

1.07

1.4

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

203

1.43

1.05

1.2

1.1

—

(3010421) pH of Blood

175

1527

1.15

1.04

4.8

3.7

7.42

0.06

137

1386

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

276

0.65

1.02

1.2

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

618

5770

1.08

1.02

1.4

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.92

1.02

1.6

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.89

1.01

1.7

1.6

46.50

45.96

umol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

106

1256

0.84

1.00

1.5

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

107

1.59

0.99

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

356

0.70

0.99

1.3

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

116

985

1.18

0.98

2.0

1.8

183.80

204.27

pmol/l

1.49

104

922

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.67

0.97

6.8

7.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

140

1.50

0.97

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

217

2428

0.89

0.94

1.2

1.3

—

(3018133) Calcium [Moles/volume] in Urine

1.77

0.94

1.0

1.6

3.26

2.52

mmol/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

102

861

1.19

0.94

1.8

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.78

0.94

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

364

1.29

0.94

1.1

68.00

133.39

titre

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

295

1.32

0.92

1.3

1.5

4.42

3.96

0.08

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

304

1.32

0.91

1.2

1.5

0.20

0.23

nmol/l

0.21

233

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

0.91

1.2

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

261

1.34

0.91

1.1

345.57

302.29

mg/l

0.55

230

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

255

0.67

0.90

1.2

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

193

1.40

0.90

1.3

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

102

866

1.18

0.89

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

637

1.21

0.89

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

385

1.27

0.89

2.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

254

0.67

0.88

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

253

0.67

0.87

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

253

0.67

0.87

1.2

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

290

1.31

0.86

1.0

1.1

2.18

2.48

u/ml

0.09

108

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.94

0.84

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

104

1.54

0.84

1.7

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

213

1.36

0.84

1.1

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.76

0.83

9.5

5.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.74

0.82

1.4

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

391

1.26

0.80

1.0

1.1

0.78

1.02

u/ml

0.34

204

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

228

2064

1.11

0.80

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

106

1.51

0.78

1.3

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.51

0.77

1.0

1.3

—

(40762814) Titanium [Mass/volume] in Blood

140

1.43

0.76

1.7

2.2

2.56

3.79

ug/l

—

(3019174) dRVVT (LA screen)

1.77

0.76

1.3

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

485

1.22

0.76

2.3

1.9

509.89

2286.01

u/l

1.28

184

(3017446) Testosterone [Moles/volume] in Serum or Plasma

469

4398

1.07

0.75

2.5

2.1

11.27

12.49

nmol/l

2.54

392

3857

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.00

0.72

2.2

1.4

258.00

313.12

umol/24h

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.80

0.72

1.4

2.1

16.51

17.67

umol/l

—

(3025130) Human papilloma virus identified in Specimen

317

1.26

0.71

1.5

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

117

1.45

0.71

1.0

2.4

1.37

1.05

ug/l

0.25

110

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.75

0.71

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.58

0.71

1.7

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.58

0.71

1.7

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.58

0.71

1.7

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.58

0.71

1.1

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.92

0.70

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

203

1.33

0.70

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

694

1.17

0.68

1.9

1.8

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.67

0.68

1.1

1.4

—

273.62

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1091

0.87

0.68

3.6

3.7

59.68

58.08

0.77

1091

(3051101) Glucose [Moles/volume] in Cord blood

120

0.58

0.67

4.3

6.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

452

0.80

0.67

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

447

1.21

0.67

1.0

274.00

345.50

ng/l

1.39

292

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

447

1.21

0.67

1.0

667.50

725.79

ng/l

0.53

284

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.79

0.66

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.79

0.66

1.2

2.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

373

0.78

0.66

1.6

1.4

103.54

195.34

pmol/l

2.45

373

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.54

0.65

1.1

1.3

39.69

1207.05

ng/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

450

1.20

0.63

1.0

39.63

47.40

ng/l

0.66

289

(3023511) Choriogonadotropin [Units/volume] in Urine

207

1.31

0.63

1.6

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1506

14634

1.04

0.62

3.0

3.2

0.76

0.79

ug/l

0.38

1042

10349

(3002619) Bacteria identified in Specimen by Culture

121

1.41

0.62

1.2

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

211

0.71

0.62

1.1

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1049

0.88

0.61

3.4

3.3

4.21

4.29

e9/l

0.18

1049

(40768795) Lymph node Pathology biopsy report

566

0.83

0.61

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

290

1.24

0.59

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

290

1.24

0.59

1.4

1.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.48

0.57

1.0

1.1

3.55

13.55

u/ml

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

184

0.71

0.56

1.2

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

495

0.83

0.56

1.4

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

206

0.73

0.55

1.2

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

785

1.14

0.55

1.6

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

973

0.88

0.53

1.5

1.3

—

(3005033) Fetal Nuchal fold Thickness US

204

0.73

0.52

1.1

1.4

—

(3025577) Chromium [Mass/volume] in Blood

490

1.16

0.51

1.9

2.0

1.83

2.19

ug/l

0.77

410

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

148

1352

1.10

0.51

1.9

1.7

37.02

44.93

nmol/l

5.21

134

1288

(3034426) Prothrombin time (PT)

145

0.69

0.50

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

462

0.84

0.46

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.43

0.46

2.9

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.40

0.45

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

121

1.32

0.44

1.0

1.2

88.14

83.11

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

405

0.84

0.43

1.2

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

148

1.28

0.43

1.2

29.45

35.53

0.25

100

(3044007) Cell count panel - Peritoneal fluid

157

1.27

0.43

1.9

1.8

—

(40768793) Breast Pathology biopsy report

1008

0.90

0.43

1.4

1.3

—

(1002224) Polysomnography panel

146

1347

1.09

0.43

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

897

1.11

0.42

1.3

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

122

1.31

0.42

1.0

1.1

89.00

82.20

—

(3044009) aPTT.lupus sensitive (LA screen)

1.56

0.42

1.4

1.2

—

(3000012) Reticulocyte production index

102

927

1.10

0.41

1.8

2.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.13

—

(3020393) Adenovirus Ag [Presence] in Stool

1.36

0.41

1.0

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.40

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.40

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.40

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.40

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

465

0.86

0.40

1.2

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.14

—

(3013862) HLA-DP [Type]

0.00

0.40

0.0

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.34

0.39

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.43

0.39

5.6

8.4

124.80

44.56

g/mol

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.43

0.39

1.4

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.41

0.39

1.5

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.32

0.37

1.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

113

0.71

0.37

1.3

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

107

1.31

0.37

1.1

1.2

—

(4034850) Laboratory test

172

1836

0.94

0.37

10.7

10.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

328

1.16

0.36

1.0

1.1

3.56

2.61

u/ml

0.29

153

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.43

0.35

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.31

0.35

1.3

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.40

0.35

1.2

2.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

145

1.24

0.33

1.1

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

109

1.28

0.33

3.6

2.5

2710.21

1232.49

u/l

0.41

104

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

210

0.81

0.33

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

606

1.11

0.32

1.1

1.2

1.72

5.12

u/ml

1.82

205

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

120

1.25

0.30

1.3

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

175

1.20

0.30

1.1

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

366

0.87

0.28

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

312

0.86

0.28

5.1

4.4

293.06

91.17

u/ml

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

472

1.10

0.26

1.1

1.22

3.28

u/ml

3.30

159

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

138

0.80

0.25

1.0

1.3

310.83

150.00

nmol/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

397

1.11

0.24

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

142

1.20

0.24

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

804

1.07

0.23

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

534

1.09

0.22

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

304

1.12

0.22

1.1

1.3

0.59

1.66

u/ml

1.07

178

(3023323) Follitropin [Units/volume] in Serum or Plasma

709

1.07

0.22

1.4

23.65

29.27

iu/l

0.90

595

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

238

1.13

0.22

7.7

3.9

35.67

55.28

u/ml

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

3.9

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

3.46

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

595

1.08

0.20

1.2

3.57

3.58

u/ml

0.00

264

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

187

0.86

0.20

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

1.22

0.20

1.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.22

0.20

1.2

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

115

0.78

0.20

1.0

1.1

—

(3012501) Base excess in Blood by calculation

138

1320

1.05

0.19

4.6

3.8

2.26

2.63

mmol/l

1.27

108

889

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.13

0.18

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

138

1.16

0.17

2.0

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

224

1.12

0.17

1.4

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

204

0.88

0.16

6.6

6.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

111

1.17

0.15

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

264

1.10

0.15

1.0

1.1

0.74

0.35

u/ml

0.35

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

264

1.10

0.15

1.8

2.8

35.65

36.52

0.11

166

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

245

1.10

0.15

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

554

0.94

0.15

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

112

1.16

0.14

1.2

1.9

—

(44813793) Dust mix specific IgE antibody measurement

295

1.09

0.14

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

161

1.12

0.13

1.3

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

489

4966

0.98

0.12

4.4

3.2

1.23

mmol/l

0.03

443

4197

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

609

1.05

0.12

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

148

0.88

0.12

1.2

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

643

1.04

0.10

1.6

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.14

0.10

1.0

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

402

0.94

0.10

1.9

2.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.11

0.09

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.06

0.09

1.4

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.04

0.09

1.8

2.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

252

1.07

0.09

1.4

1.2

—

(4212803) Bone marrow aspirate examination

1.11

0.09

1.2

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.11

0.09

8.0

6.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

233

1.07

0.09

1.3

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.09

0.08

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.05

0.08

1.3

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.81

0.08

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.14

0.08

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

195

1.08

0.08

1.0

1.1

8.25

4.50

u/ml

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

294

1.05

0.07

1.8

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.07

0.07

1.7

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.06

0.07

1.2

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.05

0.07

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

206

1.07

0.07

1.0

—

(40765096) Chromosome analysis panel by Banding

206

1.07

0.07

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.02

0.07

1.7

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

130

1.08

0.04

1.1

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

312

0.96

0.04

1.2

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

925

0.98

0.03

2.0

1.6

1.78

1.67

mmol/l

0.51

899

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

132

1305

1.01

0.03

1.6

4.18

3.81

mg/l

0.08

102

944

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

142

1.06

0.02

1.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

144

1.04

0.00

1.1

0.41

0.59

u/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

174

1.03

0.00

1.1

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

316

0.98

0.00

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

316

0.98

0.00

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

316

0.98

0.00

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

313

0.99

0.00

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

312

0.99

0.00

1.2

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

748

1.00

0.00

1.9

1.6

88.99

89.03

0.02

733

(3014599) Egg white IgE Ab [Units/volume] in Serum

139

1.01

0.00

1.1

9.40

1.27

u/ml

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

159

1.01

0.00

1.8

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

0.91

0.00

1.0

1.2

0.44

2.16

mmol/l

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.9

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.87

0.00

1.7

1.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

2.7

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

300

1.00

-0.00

1.4

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

1.4

—

6.40

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

1.50

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.3

—

(3000285) Sodium [Moles/volume] in Blood

0.94

-0.00

1.7

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.96

-0.00

3.0

1.6

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

32.40

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

84.40

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.00

-0.00

1.1

1.3

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

19.00

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

6.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_FH and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_FH	1.354 [1.23, 1.49]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.143

During the follow-up period (1.1.1998 — 31.12.2019), 6158 out of 21580 females with E4_FH died.

Males

Parameter	HR [95% CI]	p-value
E4_FH	1.442 [1.31, 1.59]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 7033 out of 24176 males with E4_FH died.

Mortality risk

Mortality risk for people of age

years, who have E4_FH.

N-year risk	Females	Males
1	0.123%	0.314%
5	0.761%	1.636%
10	1.933%	4.213%
15	3.509%	8.179%
20	6.254%	13.691%

Relationships between endpoints

↥

Index endpoint: E4_FH – Familial hypercholesterolemia

GWS hits: 29

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Familial hypercholesterolemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints